A new report from the Columbia University Water Center, in conjunction with Veolia Water and Growing Blue, reveals that businesses and cities in America’s most iconic regions are now under greater risk of water scarcity. Utilizing a new research metric called the Normalized Deficit Cumulated (NDC) index in the America’s Water Risk: Water Stress and Climate Variability study, Columbia identifies top ten U.S. areas facing the highest climate-related risk of water shortages, including Washington, D.C and New York City. (PRNewsFoto/Growing Blue)

Posted by Heidi Schwartz

A new report from the Columbia University Water Center, in conjunction with Veolia Water and Growing Blue, reveals that businesses and cities in some of America’s most iconic regions are now under even greater risk of water scarcity.

The post New Report Reveals The 10 U.S. Areas Facing The Highest Climate-Related Risk Of Water Shortages appeared first on Business Facilities.

The FAA currently is evaluating six U.S. sites as potential test flight centers for Unmanned Aerial Vehicles (UAV), also known as drones (the Wright-Patterson facility in Ohio is a leading contender). Most of our elected representatives in Washington are gung-ho for the idea, especially in districts with manufacturers who would thrive if the demand for “domestic” drones takes off. Thus far, they’ve been stymied by a handful of civil-liberties and air-safety fuddyduddys who wonder whether filling our skies with robot planes will fatally compromise our right to privacy, to say nothing of the occasional commercial airliner they may bump into.

While we’ve been watching the skies, it looks like the ground may have shifted under our feet.

The plans for mass-producing driverless cars aren’t even on the drawing boards of the major automakers, but a new survey shows that an astounding 60 percent of U.S. motorists are ready to welcome robot cars on American roads.

IT networking giant Cisco this week released the results of its study on the importance of high-tech gadgets to today’s car buyers. Not surprisingly, the Cisco survey found consumers completely enamored with the latest computer-driven automotive capabilities, from cars that park themselves to voice-activated menus for nearby Chinese restaurants.

But the real eyebrow-raiser in the survey was the response to Cisco’s question asking drivers whether they’re ready to trust driverless cars to drive them around.

The results are fascinating. Three nations with emerging automotive markets — and, presumably less experience with driving — gave driverless cars the biggest thumbs up. About 95 percent said yes in Brazil, 86 percent in India and 70 percent in China. They were followed by the U.S. at 60 percent, Russia at 57 percent and Canada at 52 percent.

But in Japan, the nation that has the most experience with robots of any kind, only 28 percent of respondents indicated they would be inclined to slide into the passenger seat of a driverless car. Also, when the risk-taking is expanded from the individual to the family, enthusiasm predictably declines for the driverless car. Fewer respondents in the Cisco survey said they were willing to put their kids in a robot vehicle.

The Cisco survey results may reflect the shape of things to come. Driverless cars probably will be tooling down a highway near you sooner than you think.

The psychological roadblock to the driverless vehicle apparently was shattered by the Google car. The Internet search giant’s robot test vehicle thus far has logged more than 300,000 miles without incident. Google says the technology for a true “fully autonomous driverless car” is still about five years away. Motor Trend, the car magazine, predicts that driverless cars will be in mass production by 2025.

The Cisco survey also revealed that consumers’ trust for automated vehicles extends beyond the steering wheel: the study found that 74 percent of drivers would be fine with their car tracking their driving habits if they could save on insurance and maintenance costs; 65 percent said they would be willing to share their height, weight, driving habits and entertainment preferences with car manufacturers in return for a more “custom” driving experience.

In the same week that Cisco’s survey results were released, the National Transportation Safety Board has proposed to lower the federal blood alcohol level threshold for drunk driving from .08 to .05, a drop of more than a third from the current standard.

Coincidence? We think not. Obviously, there’s some sort of a master plan falling into place here:

STEP 1: Track our movements with drones.

STEP 2: Take our car keys away.

STEP 3: Ply us with alcohol and entice us to recline in the ergonomically designed passenger seat of a driverless car that knows we can be lulled into a mindless sense of euphoria by the smell of Corinthian leather and the sound of Bohemian Rhapsody coming out of 16 speakers.

STEP 4: Deposit us at mass “rehabilitation” centers that have secretly been constructed on former ballistic missile launch sites in the Great Plains.

STEP 5:

(transmission interrupted, contact with human terminated)

Note: There is a poll embedded within this post, please visit the site to participate in this post’s poll.

The post They’re Coming to Take Us Away appeared first on Business Facilities.

PMF’s existing 120,000 square foot facility in North Central Pennsylvania.

Posted by Heidi Schwartz

Gov. Corbett has announced that Pennsylvania is expanding its commitment to advance clean, alternative and renewable energy sources with the investment of more than $9.6 million in 13 projects in 11 counties.

The post Clean Energy Investments In Pennsylvania Will Create Jobs, Leverage $109 Million appeared first on Business Facilities.

Facebook’s Prineville, OR data center

By Bill Trüb
From the March/April 2013 issue

Data centers are crucial to operations across countless sectors, from retail to information technology, government to biotech, logistics to engineering. Many consumers, however, have little awareness or understanding of just how massive and expensive these facilities are. Large-scale data centers are known to use the amount of electricity equivalent to small towns and, despite many greening initiatives, some centers release a significant amount of air pollution in the form of diesel exhaust. Furthermore, the amount of security necessary to run a successful data center is enormous due to the highly sensitive information and pricey equipment housed in such storage units. So high are these stakes that the Telecommunications Industry Association has even published a document detailing the minimum requirements for the infrastructure of data centers and computer rooms.

But the business of IT is one that changes quickly. The International Data Corporation claims the average data center is nine years old, which is troubling when coupled with research company Gartner’s assertion that data centers more than seven years old are obsolete. In May 2011, Uptime Institute reported that 36 percent of large companies will exhaust their IT capacities within the next 18 months. Yet according to a “Green Data Centers” report by Pike Research,the global market for green data centers segment of the industry is expected to more than double in size in the next four years. It can be overwhelming to try and keep abreast of these fast-moving, ever-changing, air-conditioned rooms of priceless information.

Greene And The Greening Of Data Centers

In an effort to reduce the shocking levels of diesel exhaust that many data centers emit into the atmosphere, the industry is being proactive in finding environmentally sound operating solutions. Aptly-named Nicholas Greene, writer for www.greendatacenterconference.com, penned “Ten of the Biggest Data Center Trends” at the tail end of 2012. Let’s recap a few of his most notable prognostications.

“Cloud Computing’s still got a long way to go before it’s the world-changing behemoth that everyone predicts it will be, but this year saw more and more organizations finding their way to cloud computing, and loving every moment of it,” writes Greene. “Hybrid clouds took off, and Infrastructure-as-a-Service, Software-as-a-Service and Platform-as-a-Service vendors really came into their own. Unfortunately, the great strides cloud computing made this year are going to have some unfortunate side-effects in the near future. Moving forward; scalability is going to be a huge concern: our current data center infrastructure, powerful as it is, might not be able to handle the increased demands of the cloud.”

Greene continues, “2012 also witnessed the birth of the software defined data center. As a direct result of this, we’ve been seeing an increased focus on virtualization with the configuration of the data center’s hardware dealt with by upper-level software. Software Defined Networking, though still in its nascent stages, has the very real potential to revolutionize the way data centers are operated, with new options for resource optimization, availability, storage, and mobility.”

According to Greene, the push for eco-sensitive options has been a success. “The environment has been getting a lot of love from data center operators this year,” he says. “We’ve been seeing a massive shift towards green computing throughout 2012, with big names such as Apple and Microsoft hopping on the environmental friendliness train. The looming threat of global warming, coupled with the obvious energy savings one accrues as a result of green initiatives (not to mention the good press an organization can receive) have combined to make green IT a near-integral part of data center design.”

Greene gives us the word of the year: “Server racks are becoming denser and denser as many organizations consolidate their data centers in order to save on energy and real-estate costs. Consolidation is the word of the year, as data centers grow smaller and more powerful and energy management turns from a good idea to an integral discipline for data center operation.”

And finally, openness and transparency is where the industry is headed, led by kingpins Facebook and Google. “In April 2011, Facebook founded the Open Compute Project—an initiative which I’m sure that many initially took as a very bad April Fool’s Joke. It wasn’t—and it’s been gaining steam ever since,” asserts Greene. “The notion that data centers should be defined by their software infrastructure rather than their physical hardware seemed novel at the time, but Facebook has demonstrated that it’s got real value. Even organizations that are typically secretive to the point of paranoia, such as Google, have loosened up a bit, giving us some insight into the inner workings of some of their facilities. Maybe one day in the future, Facebook’s ideals will pay off, and we’ll be rewarded with true transparency in data center operations.”

Google Searches, Hits On South Carolina

Speaking of such Internet giants, Google held a groundbreaking ceremony in January in Berkeley County, SC to announce it will expand its operations at the Mt. Holly Commerce Park. The additional $600 million in investment at the site brings Google’s total investment to more than $1.2 billion. The data center in Berkeley County currently houses thousands of servers to support services such as Google search, Gmail, Google+ and YouTube. As Google’s services grows, the company must ramp up its data centers to meet demand.

Google’s data center in Berkeley County, SC. Google is using the rainwater retention pond as another means for cooling its data center.

“Today’s announcement is another big win for South Carolina,” says Governor Nikki Haley. “We celebrate Google’s decision to grow its footprint in Berkeley County with a $600-million investment. When a world-class company like Google decides to expand in the Palmetto State, it shows we are providing the sort of business environment that helps foster success.” Many states aggressively pursue data center business through various tax incentives because data centers are often a boon for local economies.

“South Carolina and the Berkeley County community are great places in which to work and grow,” says Data Center Operations Manager Eric Wages. “When Google first announced plans to come to Berkeley County in 2007, we were attracted to not only the energy infrastructure, developable land and available workforce, but also the extraordinary team from the local community that made us feel welcome. Today’s announcement is just a continuation of our investment in the state. Google is proud to call Berkeley County home.”

Google first announced plans for a South Carolina data center in 2007, making an initial investment of $600 million to get the center up and running. In November 2010, Google announced plans to construct a second building at the site, which is now serving traffic.

Google is also involved in supporting science and mathematics programs in South Carolina’s schools. Since 2008, it has awarded more than $885,000 in grants to local schools and nonprofits. It also has helped implement a free, downtown Wi-Fi network in Goose Creek.

“Google has been a great partner, exceeding expectations when the data center was first proposed,” says Berkeley County Supervisor Dan Davis. “They have invested capital, created good jobs and more importantly partnered with local businesses to help them do business better.”

“When our community came together to develop this business park, we wanted to attract leading companies that would establish deep roots and grow,” says South Carolina Sen. Paul Campbell. “Google’s expansion is an example of how Berkeley County can serve the needs of the world’s most innovative and dynamic companies. I hope Google’s growth here prompts other growing businesses to put down roots.”

Facebook ‘Likes’ Oregon

Facebook stores more than 240 billion photos, with users uploading an additional 350 million new photos every single day. To house those photos, Facebook’s data center team deploys 7 petabytes of storage gear every month. But what do you do with an exabyte of digital photos that are rarely accessed? That was the challenge facing Jay Parikh, Vice President of Infrastructure Engineering at Facebook.

The team decided a dedicated data center at its Prineville, OR campus could house older photos in a separate “cold storage” system and would dramatically slash the cost of storing and serving these files. The facility has no generators or UPS systems, but can house up to an exabyte of data.

Last year, Facebook built a 62,000-square-foot data center on its Prineville campus to house its cold storage, which can house 500 racks that each hold 2 petabytes of data, for a total of 1 exabyte of cold storage. Similar facilities will be built at Facebook’s data center campuses in North Carolina and Sweden, Parikh said.

The cold storage data center has no generators or uninterruptible power supply (UPS), with all redundancy handled at the software level. It also uses computer room air conditioners (CRACs) instead of the penthouse-style free cooling system employed in the adjacent production data centers in Prineville.

Most importantly, each rack uses just 2 kilowatts of power instead of the 8 kilowatts in a standard Facebook storage rack. But Parikh said it will be able to store 8 times the volume of data of standard racks. Not many companies face storage challenges at the kind of scale seen at Facebook. But Parikh believes more companies will be confronting these massive storage issues.

“Our big data challenges that we face today will be your big data challenges tomorrow,” he says. “We need to keep coming up with advanced solutions to our storage problems. The most important innovations are the problems people solve before the scale of the problem emerges. I believe big data is one of those problems. And we won’t keep up unless we work together.”

Facebook completed a second huge data center on its campus in Prineville, Oregon in 2012. The facility is similar to its existing 300,000-square-foot data center, Facebook Data Center Manager Ken Patchett announced at a Prineville City Council meeting.

“We believe the construction of the phased expansion of Building 2, and the operation of Building 1, staffing and supplying of the Prineville Data Center will continue to have a positive impact on the Crook County-Prineville economy,” Patchett told the city officials.

The second building in Prineville created up to 450 construction jobs, with the project lasting approximately one year. At the time, Facebook said it would add 10 full-time jobs in Prineville, where it currently employs 54 full-time employees providing building maintenance, security and server maintenance. The Prineville project is Facebook’s first company-built facility, and is optimized from the two-story structure right down to the servers to reflect the company’s vision for energy efficient data center operations.

CoreSite Realty Picks NJ

CoreSite Realty has purchased a 280,000-square-foot building in Secaucus, NJ for a new data center, and expects to invest $65 million to buy the facility and redevelop the initial phase of 65,000 square feet of data center space.

The facility, which will be dubbed NY2, is the company’s first data center in New Jersey and a sign of continuing activity in the northern NJ market. CoreSite already has a site in New York City and the Secaucus facility will mark an important expansion for the provider.

CoreSite is under contract to acquire the building, with the acquisition expected to close in early February. The 280,000-square-foot facility sits on 10 acres of land, which allows additional data center development as the market demands. At full build out, CoreSite expects it will offer 19 critical megawatts of capacity. Construction will start in Q1 2013, with turn-key capacity expected to be available in Q4 2013.

CoreSite intends to ensure the availability of high-capacity and high-speed lit services as well as a robust dark-fiber tether between NY2 and CoreSite’s NY1 location at 32 Avenue of the Americas in Manhattan, enabling CoreSite to provide seamless interconnection across its New York campus.

The company has been aggressively building out data center campuses across America. Focusing on network centric and cloud oriented applications, these data center campuses are network-dense.

“CoreSite’s entry into Secaucus is an important step in the execution of our strategy to extend our U.S. platform supporting latency-sensitive customer applications in network-dense, cloud-enabled data center campuses,” says Tom Ray, President and Chief Executive Officer, CoreSite. “Our New York campus is designed to meet performance-sensitive customer requirements supported by our location at the nexus of robust, protected, low-latency network rings serving Manhattan as well as global cable routes to Chicago, Frankfurt, London, and Brazil. Additionally, customers are able to connect directly to service nodes for Amazon Web Services Direct Connect.”

The Secaucus facility follows the launch of CoreSite’s previously announced 15 data center, located in Reston, VA. CoreSite’s national platform spans nine US markets and includes more than 275 carriers and service providers and more than 15,000 interconnections.

The availability of direct connections to high speed networks in NY2 will be of particular interest to financial firms looking to reduce latency and improve performance. Three network service providers have pre-committed to serve NY2, consisting of CoreSite partners Sidera Networks, Zayo, and Seaborn Networks, each of which provides high-performance network support to the financial services, cloud and network communities.

“The new CoreSite data center in New Jersey fits perfectly with Sidera’s growth strategy,” says Clint Heiden, President, Sidera Networks. “This expansion gives CoreSite customers immediate access to over 40 financial exchanges and the Sidera Xtreme Ultra-Low Latency Network.”

In addition to the new facility, the company also announced an Open Cloud Exchange, an initiative looking to offer a range of cloud services to customers. The Exchange will offer best-of-breed partnerships and services from a broad range of providers. It capitalizes on demand for hybrid infrastructures, letting Enterprises, Managed Service Providers (MSPs) and Systems Integrators (SIs) in CoreSite facilities connect directly, via a single resource, to the cloud service providers of their choice. This provides customers with flexible options to securely and easily connect to all types of cloud offerings.

“We’re building the industry’s premier home for cloud services,” says Jarrett Appleby, COO, CoreSite. “With networks—the oxygen for cloud services—as the foundation, adding the industry’s leading cloud providers will create best-in-class scalability, management, automation, software, and many-to-many exchange capability. The Open Cloud Exchange offers our customers enormous provider flexibility, guaranteed performance, real-time monitoring, and easy management of cloud infrastructure services.”

The initial four best-of-breed partners in Open Cloud Exchange are CENX, Rightscale, RiverMeadow Software and Brocade.

• CENX will provide its CENX Automated Ethernet Lifecycle Management software specially designed for CoreSite’s Open Cloud Exchange, enabling easy, single sign-on management of Layer 2 cloud infrastructure services and full MEF CE 2.0 compatibility.
• RightScale, will provide its platform for deploying and manage business-critical applications across public, private, and hybrid clouds. RightScale offers efficient configuration, monitoring, automation, and governance of cloud computing infrastructure and applications.
• RiverMeadow Software will deliver its automated cloud onboarding SaaS developed specifically for migrating servers and workloads into and between Carrier Service Provider Clouds.
• Brocade will provide the hardware infrastructure and switching logic at the heart of the Open Cloud Exchange.

Planned future enhancements include the ability to connect to providers across multiple CoreSite locations within the same metro area; connections between customers and providers in various on-net buildings throughout the country; and the Choice between numerous software and services providers to support performance sensitive customer applications through a marketplace portal. The service is available immediately in seven campuses: Los Angeles, San Francisco Bay Area, Chicago, New York, Northern Virginia, Boston, and Washington, DC.

In addition to this monster of a facility from CoreSite, Northern New Jersey has been no stranger to activity these last few months. Internap announced a 100,000-square-foot project in Secaucus last October, its third in the NY Metro region, to address growing demand. With its supply of data center space in northern New Jersey running low, Digital Realty recently announced construction in Clifton.

Apple Blossoms In NC

Apple currently is building huge new data centers in three states, including the North Carolina iDataCenter. Meanwhile, it is leasing large quantities of data center space in California’s Silicon Valley.

Many of the largest cloud computing providers opted to lease new Internet infrastructure in 2012, according to new data from a veteran market watcher. The report highlights the shifting tides in the “buy or build” decision, in which geography and market economics are contributing to a two-tier infrastructure for many of the largest Internet players, with footprints split between company-built data centers and wholesale space.

Apple, Facebook and Microsoft were among the largest consumers of turn-key “wholesale” data center space in 2012, according to Jim Kerrigan, Director of the Data Center Group at Avison Young. Microsoft leased 12 megawatts of new wholesale space in 2012, with Facebook (10 megawatts) and Apple (8 megawatts) not far behind.

The trend is notable because all three companies have recently been building their own massive data center facilities. Facebook has 1.5 million square feet of data center space that is either built or nearing completion, while Apple has finished its huge iDataCenter in North Carolina and is building new facilities in Oregon and Nevada. Microsoft has built its own server farms in seven sites around the U.S. and Europe over the past 5 years.

After years of building huge data centers in remote areas, in 2012 the geographic focus shifted back to historic Internet hubs in northern Virginia, Silicon Valley and Chicago. Apple and Facebook have moved armadas of servers to rural locations in North Carolina and Oregon that offer cheap power and cheap land. Cloud builders will continue to do this going forward, but a portion of their infrastructure must always be housed near the Internet’s key intersections, where they can connect with dozens of other networks. Both land and power are more expensive in these Internet hubs, resulting in different economics for large-scale new construction. That’s why the largest wholesale data center providers have a large presence in these markets.

General Motors Gets Specific In Georgia

General Motors announced plans to hire approximately 1,000 high-tech workers to staff its new Information Technology Innovation Center near Atlanta. The automaker needs software developers, project managers, database experts, business analysts and other IT professionals for the third of four centers in the United States.

“Locating this center in Atlanta makes good business sense,” says GM Chief Information Officer Randy Mott. “We can draw from a deep pool of high tech expertise through the surrounding colleges, universities and talent residing in the area.”

“This Innovation Center is exactly the kind of employer we want in the state,” says Georgia Gov. Nathan Deal. “The information age will be with us for a long time, and attracting companies such as GM that are on the cutting edge of manufacturing and technology is a huge win for Georgia.”

Mott is leading a rebalancing of information technology at GM under which the majority of IT work will be done by GM employees instead of being outsourced, which has been the GM model for most of the last three decades.

“We look to the Innovation Centers to design and deliver IT that drives down the cost of ongoing operations while continuously increasing the level and speed at which innovative products and services are available to GM customers,” Mott says. “The IT Innovation Centers are critical to our overall GM business strategy and IT transformation.” The location of the fourth site will be announced at a later date.

Gartner’s View On Cloud Computing

Drue Reeves, Gartner’s Vice President and distinguished analyst, recently outlined five trends that will transform the data center industry for Computer Weekly. Reeves’ expert predictions focus heavily on cloud computing, which requires the use of computing resources (both hardware and software) that are delivered over a network, usually the Internet. The name comes from the use of a cloud-shaped symbol as an abstraction for the complex infrastructure it contains in system diagrams. Cloud computing entrusts remote services with a user’s data, software and computation. Here are Reeves’ five trends, in his own words, for the future of data centers.

• Hybrid IT: Perhaps the greatest effect of public cloud computing on IT concerns operations. IT organizations realize that not only do they need to compete with public cloud service providers (CSPs), but also act as intermediaries between internal customers and all IT services (internal or external). IT organizations are becoming brokers of a set of IT services hosted partly internally and partly externally — that is, of hybrid IT. As intermediaries, IT organizations can offer internal customers the price, capacity and provisioning speed of the external cloud, and the protection and security of the internal cloud.
• Internal clouds: When businesses grow accustomed to consuming IT as a service, IT organizations will be compelled to build internal clouds. Unfortunately, building an internal cloud is hard work and few blueprints exist. Although vendors are building products that will help customers build internal clouds, there is no turnkey solution. IT organizations will struggle to cobble together the necessary pieces to build internal clouds. Nevertheless, building them will be a key data center trend in 2012 because of the need to compete with external cloud computing.
• Hybrid clouds: Hybrid clouds are connections between two clouds, usually an internal private cloud and an external public cloud. They are constructed using software that enables applications and data to migrate more easily between clouds. For example, many applications depend on identity management systems to authenticate users, have gigabytes of data, and have input/output latency dependencies for storage. These attributes often prevent applications from migrating to the external cloud, but hybrid cloud solutions them in unique ways. For example, hybrid cloud software can enable WAN acceleration and VPN connections between clouds that allow IT organizations to keep application services and critical data in the internal cloud, and to move the workload itself to the public cloud. As IT budgets continue to shrink and capital resources remain scarce, hybrid clouds will become a more popular option for augmenting IT capacity and enabling disaster recovery than building another data center or signing a long-term outsourcing agreement.
• User-centric computing: To compete in a global market and retain key employees, organizations often have to accommodate staff who live in remote locations and use personal devices for work. Some organizations are attempting to radically reduce the operational expense of supporting numerous desktop devices for large groups of users with various application requirements. These needs create new challenges for IT organizations to secure data; back up data; support smaller, less functional devices; and support a broader range of devices. Therefore, many IT organizations are rethinking their desktop and mobility strategies and adopting a user-centric, rather than a device-centric, point of view.
• Data center efficiency: Competing with the external cloud requires IT organizations to strive for hyper-efficiency in their data centers. If critical data and applications are to be housed in an internal private cloud, IT organizations must deliver internal IT services in an efficient, cost-effective manner. This requires them to squeeze further costs out of their data centers by virtualizing as many applications as possible, using storage efficiency technologies such as data deduplication, and buying servers that enable them to maximize space and power and to consolidate applications.

The post FEATURE STORY: The Story Of Storage appeared first on Business Facilities.

Posted by Heidi Schwartz

The Hertz Corporation has announced that the company will relocate its worldwide headquarters to Estero, FL (Lee County, near Bonita Springs and Fort Myers) from Park Ridge, NJ. Hertz made the decision following its recent acquisition of the Dollar Thrifty Automotive Group, which was finalized on November 19, 2012. Dollar Thrifty is currently headquartered in Tulsa, OK.

Consolidating the corporate offices to one location will allow for increased efficiencies and cost synergies across the company. Additionally, access to the Florida travel and tourism population will position the company for long-term growth. According to Visit Florida, there are approximately 1 million employees in the state’s travel and tourism industry, Florida’s largest business segment. Hertz also noted that Orlando is the world’s largest car rental market, and that Miami is a hub for accelerating travel growth between the United States and Latin America.

Starting this year, up to 700 jobs will be relocated to Florida over a two-year period.  More than 2,000 Hertz and Dollar Thrifty personnel will remain in New Jersey, including approximately 150 employees who currently work in Park Ridge. All other Park Ridge employees will be able to retain their current positions at the new headquarters, scheduled to be completed in early 2015. Hertz was founded in Chicago, IL in 1918, and moved its headquarters to New Jersey from mid-town Manhattan in 1988.

“After our recent business expansion, we have been looking for the right location to blend Hertz and Dollar Thrifty head office employees,” Hertz Chairman and Chief Executive Officer Mark P. Frissora said. “Florida is the center of the U.S. travel and tourism industry—this move enables us to be closer to leisure and business customers as well as many travel and association partners. As part of this move, we will open off-airport and retail car sales stores on our headquarters campus, which will enable us to experiment with new services and monitor customer satisfaction first hand. Lee County, on the Southwestern Gulf Coast of Florida, is a well-established travel destination with tremendous growth potential, with easy access to other leading tourism markets including Orlando, Miami/Fort Lauderdale and Tampa/St. Petersburg.”

Hertz and Dollar Thrifty have more employees in Florida than in any other state except California, and Florida rents more cars per capita than any other state. Florida provides ready access to a vast and diverse talent pool, including 3,000 of its own employees. All of these factors supported the company’s final decision.

Frissora added, “This is the best, most balanced business decision based on market factors as well as the needs of our employees and customers. The relocation results in a positive financial return to the company and we will provide more details during our next quarterly earnings call. Additionally, in no way should this decision be perceived as a slight to our partners in New Jersey and Oklahoma. We recognize the significant efforts undertaken in recent years in both states to create and retain jobs, while improving the overall business climate.  In particular, over the last several years we have seen significant improvement in New Jersey’s business climate and our decision should not be interpreted as a reflection of our views about doing business in the Garden State.  New Jersey has been our home since 1988 and would have been for countless more if not for our acquisition of Dollar.

“Because of these efforts, we will continue to grow our car and equipment rental businesses in New Jersey and Oklahoma. We are retaining e-commerce and certain financial functions in northern New Jersey thanks to the state’s strength in the financial services industry.  Oklahoma will continue to be our primary home for IT, customer service and financial support driving our North American businesses.  Overall, we concluded that it is in the best interests of our company, which is primarily in the travel and tourism business, to be near our largest market.

“We also want to note that the New Jersey Partnership for Action was very active and effective in their efforts to entice us to remain in New Jersey, and we are grateful for their efforts.”

The post Hertz Announces Corporate Headquarters Relocation To Florida appeared first on Business Facilities.

By Dominique Cantelme
From the March/April 2013 issue

New York State’s 54,556 square mile geography is divided into 10 economic regions (according to Empire State Development)—Western New York, Finger Lakes, Southern Tier, Central New York, North Country, Mohawk Valley, Mid-Hudson, Capital District, New York City and Long Island. They encompass landscapes that range from farms, forests, rivers and lakes to mountains, towns and urban cities and a transportation infrastructure with airports, highways, waterways, subways, bridges and tunnels to help move its more than 19 million residents where they need to go.

Western New York provides both city and suburban living. Coverage of its 4,974 square miles is aided by I-90, I-86 and Route 219; Buffalo-Niagara International Airport; the Port of Buffalo; and four class I railroads (CSX, Norfolk Southern, Canadian National and Canadian Pacific). The region’s economy is particularly focused on manufacturing; it is home to a number of colleges, universities and professional schools such as SUNY College at Fredonia, University of Buffalo and Cornell University School of Industrial & Labor Relations; and offers attractions such as Allegany State Park and Ralph Wilson Stadium (NFL’s Buffalo Bills).

One of the largest tourism regions in the state, the Finger Lakes is located in the west-central section of Upstate New York and encompasses a pattern of 11 parallel lakes that include Cayuga, Owasco, Hemlock and Seneca.

Its nine counties (e.g., Genesee, Livingston, Ontario) provide scenery, history, farmlands, and museums over almost 5,000 square miles. The region is within a day’s travel of 10 of the largest cities in North America and navigated by I-90, I-390, the Greater Rochester International Airport and the Norfolk Southern Finger Lakes Railway.

The Southern Tier Region is located on the Pennsylvanian border of New York. Broome, Chemung, Chenango, Delaware, Schuyler, Steuben, Tioga, and Tompkins counties boast natural resources, agriculture and an educated workforce with universities that include Binghamton and Cornell and market access provided by I-81, I-86, I-88, and Route 17; three regional airports; rail service; and bus service by Greyhound, Short Line and Capitol Trailways.

The North Country is a seven county rural region that spans from the eastern shores of Lake Ontario to the western shores of Lake Champlain and houses Adirondack Park and Fort Drum. With 11,913.57 square miles, it is the largest of the regions in land area and the smallest in population. Access is provided by I-87, I-81 and Highway 401 as well as passenger air, commercial and passenger rail and port service.

The Mohawk Valley is located at the geographic center of Upstate New York and links all the major metropolitan areas together. Its 5,296.57 square miles spans six counties with numerous academic and research institutions, a highly skilled workforce and concentrations in manufacturing and IT. I-90, NYS Rt. 12 N S, I-81, I-87 and I-88 provide highway access while air service is available at the Griffiss Business and Technology Park and rail, bus and port service is available through a number of carriers and facilities.

The Mid-Hudson Region is located north of New York City and south of Albany along the Hudson River, and includes seven counties (e.g., Ulster, Dutchess, Rockland and Westchester). The 4,739.36 square miles is a mix of urban areas, waterfront cities, rural villages, farmlands and forests in the epicenter of the Boston-Washington Corridor. The region’s educated workforce, proximity to marketplace and access to water help make it a good place to do business with highways I-84, I-87, NY-17 and I-86; Stewart International Airport; the Metropolitan Transportation Authority, Amtrak, CSX and Norfolk Southern rail service; and bus and port service providing transportation options.

In the eastern part of mid-New York is the Capital Region which covers 5,199 square miles and is comprised of eight counties (e.g., Albany, Columbia, Saratoga and Schenectady). It is home to the Center for Excellence in Nanoelectronics at CNSE’s Albany NanoTech and the Center for Integrated Electronics at Rensselaer as well as Skidmore College and a number of other academic institutions. The region’s transportation network consists of the New York State Thruway, I-87 and I-88; the Albany International Airport; Albany Port Railroad Corp., Amtrak, CSX and CP rail systems; and the port of Albany Rensselaer and the New York State Canal System.

The 303.32 square miles of New York City is composed of five boroughs (Manhattan, the Bronx, Brooklyn, Queens and Staten Island) with more than 40 percent of the State’s population. Its more than 8,336,697 residents also make it the most populous city in the U.S. A tourist attraction in itself, NYC also includes major destinations such as the Empire State Building, Statue of Liberty, Ellis Island, Broadway and the Metropolitan Museum of Art and it is described as the cultural capital of the world. New York City also is the largest media market in North America and a center for the television, film, advertising, music, newspaper and book publishing industries as well as a global hub of international business and commerce.

Long Island is located at the southern tip of New York State, just east of New York City. Its 1,202.96 square miles is surrounded by Long Island Sound and the Atlantic Ocean. The region is comprised of Nassau and Suffolk counties and is known for its high quality of life as well as its geographical and industrial diversity. The Long Island Region is a magnet for commerce and industry and a world leader in technology development. Its close proximity to New York City and its access to national and international markets also make it ideal for service and manufacturing industries.

New York is home to some of the most diverse regions in the country with various people, landscapes, attractions, population sizes, land masses, and businesses. The one consistent is its propensity for economic opportunity. Banking, finance, communication, high technology, retail, manufacturing and agriculture are just some of the many industries prevalent in the Empire State. Its pro-business, pro-growth philosophy offers companies job-creating tax cuts, R&D incentives and a number of other business and financial resources along with a diverse and skilled workforce. New York provides a high quality of life for its people and offers access to various educational institutions that include public and private universities, technology colleges and graduate and professional schools for any desired trade or profession. Whether traveling by car, train, bus, boat or plane, New York can get you there.

Read on to find locations that can help your business succeed with a little bit of New York flair.

Oswego County: Active In Economic Development

Manufacturing is a strong, healthy and growing sector in Central New York’s Oswego County. Operation Oswego County, Inc. (OOC) and their partners, the County of Oswego Industrial Development Agency (COIDA), City of Oswego Community Development Office (CDO) and the Empire State Development Corporation (ESDC) have been very active in helping to finance manufacturing as well as commercial projects in Oswego County during 2012.

Some of these economic development projects which clearly demonstrate the diversity of business types that are being assisted in Oswego County by OOC, COIDA, CDO and ESDC include:

• Fulton Thermal Corporation, a global manufacturer of steam and hydronic boilers and thermal fluid heaters, constructed a 112,000-square-foot addition to their existing manufacturing and corporate headquarters in the Town of Richland. The new facility houses an 82,000-square-foot manufacturing building, a 10,000-square-foot research and development center and a 20,000-square-foot corporate office center. Primary funding assistance was provided by a $10 million tax-exempt bond issuance by the COIDA in cooperation with M&T Bank. The facility expansion was partly funded by an ESDC $1.5 million grant from the New York Upstate Regional Blueprint Fund. The $13.5 million project created 50 jobs.
• Stevedore Lofts, in the City of Oswego, was a waterfront renovation of a 42,000-square-foot warehousing facility into residential and commercial property. The property overlooks the Oswego River and is just a few blocks from downtown Oswego and Lake Ontario. The

$6.5 million project received funding assistance from the COIDA, the Oswego CDO and an ESDC Restore NY grant. The project created 15 jobs and added 29 market-rate apartments.

• The $6.9 million Seaway Lofts project in the City of Oswego received $1.5 million in funding from the New York State Housing Trust Fund/HOME and federal low income housing tax programs. In addition to state funds, financing from the city of Oswego Community Development Office, the County of Oswego Industrial Development Office and the Federal Home Loan Bank will be used to convert the 28,000-square-foot vacant building into affordable housing apartments. The project encompasses rehabilitation and adaptive reuse of the former Seaway Supply building into affordable workforce housing and will capture the historical features of the building while focusing on the use of energy-efficient construction techniques. It is being designed to contribute to the overall community vision for the neighborhood, including affordability and access for tenants with disabilities. Seaway Lofts is located directly across from the Varick Lock and Oswego River. The building was built in 1888, served as the home of the Brosemer Brewery and is listed on the National Register of Historic Places. The project will create 26 affordable-housing apartments and two jobs.
• Novelis, in the Town of Scriba, is constructing a $208 million, 180,000-square-foot expansion which adds two new high performance aluminum finishing lines for automotive industry products. These two new lines are expected to produce an additional 440 pounds of aluminum sheet per year. The project has created more than 100 new jobs and retained 651 jobs. Financing was assisted through a $5 million Empire State Development Corporation grant and funding through the County of Oswego Industrial Development Agency.
  

  United Wire Technologies in Constantia.

• Design Concepts and Enterprises, LLC, manufacturer of medical surgical sutures and suture attaching equipment, constructed a 1,634-square-foot clean room. Located in the Town of Hastings, Design Concepts sells their products in the U.S. and abroad. The $650,000 project retained six jobs and created 13 new jobs. Funding assistance was provided by the COIDA.
• After a fire destroyed their facility in the Village of Cleveland, United Wire Technologies renovated a vacant 14,000-square-foot building in the Town of Constantia. Relocating afforded them the opportunity to update and expand their facility. There is additional land adjacent to the facility onto which the company could expand further. United Wire manufactures specialty wire. The $1.4 million project retained eight jobs and will create six new jobs. Funding assistance was provided by the COIDA.

These projects represent a total investment of approximately $237 million and will create/retain 851 jobs in Oswego County. Numerous other projects are in the works and Operation Oswego County is actively engaged in assisting several manufacturing projects that are evaluating opportunities to expand in Oswego County and/or locate operations there. For more information visit www.oswegocounty.org.

Town Of Islip: A Community Of Opportunity

The Town of Islip has long been known as a leader of economic development in New York. Islip boasts the largest industrial corridor in the region, major infrastructure advantages over surrounding areas and an Industrial Development Agency (IDA) that has won renown for its continuous ability to attract new businesses. Though Islip faces many of the same challenges as other municipalities during these harsh economic times, the Town is uniquely suited for economic growth and expansion.

One of the prime reasons for Islip’s attractiveness to local, national and international businesses is the proximity these businesses have to Long Island MacArthur Airport (LIMA), which the Federal Aviation Administration has defined as being on-par with LaGuardia and John F. Kennedy Airports. Having a nationally recognized airport within Islip Town helps local companies conduct their business more effectively and efficiently. Just as MacArthur Airport helps local businesses expand, the airport itself is working to grow its presence to handle the economic demands of the future. Progress has already been made to increase the flow of business through the airport and is seen in U.S. Airway’s decision to offer daily flights to-and-from Ronald Reagan National Airport in Washington, D.C.

Just next door to Long Island MacArthur Airport is Foreign Trade Zone (FTZ) #52. FTZ #52 was created to help businesses with an international scope grow and thrive in Islip. These companies can utilize the FTZ’s singular economic status to avoid costs associated with importing and exporting goods with other countries. The FTZ sits at the intersection of a crucial transportation hub that features railways, highways and a commercial airport.

The Town of Islip has a proud tradition of business success, across a variety of industries. But special mention must be made toward three critical industries that have thrived within the town: technology, food distribution and pharmaceuticals. Many technology companies, spanning sectors from aerospace to telecommunications, have found a home in Islip. CMG Wireless, a company that produces goods for the telecommunications market, rapidly has expanded their operations to cope with the increase in demand for wireless technology. They have remained in Islip largely because the IDA was able to help them adapt and expand their facilities to ensure that business was uninterrupted. CPI Aero, a company that manufactures aircraft components, primarily for the U.S. military, was recently able to expand their operations to a new facility, and did so with the help of the Islip IDA.

Another recent success story has been the construction of a 420,000-square-foot facility to be operated by Sysco Inc., a food distribution company. Throughout the entire construction process, from planning, to building, to staffing, Sysco and the Town of Islip have worked together to address the needs of both the company and the community. The facility has been fully operational since the summer of 2012, and the demands of the facility already have created over 250 jobs with more to come. Throughout the entire recruitment process, SYSCO has placed a special focus on hiring from within the area. The distribution center boasts features such as a state-of-the-art hydrogen fuel station to power all of the forklifts in the facility. This project has been a model for how local governments, civic groups and businesses can work together and be proud of the finished product, which will keep all parties satisfied for years to come.

And most recently in 2012, Islip welcomed Ascent Pharmaceuticals, a pharmaceutical manufacturer whose operations involve research, development and the manufacture, warehousing and distribution of generic prescription medicines in a wide range of therapeutic areas. With the assistance of the Islip IDA, the company, owned by InvaGen Pharmaceuticals, purchased and renovated an existing 250,000-square-foot facility for $20 million and they expect to invest another $19 million in additional equipment and research. In return for financial assistance, Ascent has pledged to hire 100 new employees immediately, another 150 in the following three years and projects to employ a total of 350 when fully operational within five years. The story of Ascent

Pharmaceuticals is another example of how a company can grow and thrive in Islip, a community that understands the dedication and commitment necessary for projects like this to come to fruition.

Through all of these developments, the Islip IDA has continuously demonstrated its ability to work with businesses to build partnerships between government, businesses and residents. As a result of its many accomplishments, the Islip IDA was named the 2011 Suffolk County IDA of the Year by the editorial staff of the Long Island Business News. Islip Town will always be committed to exploring new ways to bring jobs and opportunities to Islip, without losing their identity as a community.

For information on how your business can grow in Islip, please visit www.islipida.com.

Buffalo Niagara: Four Billion Reasons To Relocate

Between yesterday, today and what will come tomorrow, there will be $4 billion in recent, current and planned development in Buffalo, New York. These investments reflect a new spirit of collaboration through public and private partnerships that focus on creativity, flexibility and a shared vision with strategic and attainable goals for business and community development.

In the last decade the city of Buffalo experienced more than $1.5 billion in new investment. The vision of a new Buffalo Niagara Medical Campus (BNMC) focused on bioinformatics, life sciences, emerging technologies, clinical care, entrepreneurship and research has spurred critical growth. As a result, state-of-the-art, multidisciplinary facilities like the Hauptman-Woodward Medical Research Institute; the one of a kind shared facility that boasts Kaleida Health Gates Vascular Institute, the University at Buffalo’s Clinical and Translational Research Center and the independent Jacobs Institute; and Roswell Park Cancer Institute are having a tremendous impact on the city’s economy, with more than 5,000 jobs created or relocated to this innovation hub since 2003, and another 5,000 expected in the next five years.

Today, another $1.5 billion in projects are underway on the BNMC, the central business district and Buffalo’s waterfront. These include critical components like the University at Buffalo relocating its highly ranked medical school to the BNMC. Also on the site, the new John R. Oishei Children’s Hospital has just broken ground. To support these facilities, new medical offices and other operations are growing around the campus footprint, providing essential services and business infill.

And the region’s rebirth isn’t limited to the life sciences industry. New projects also include the evolution of the region’s manufacturing base from its steel roots to clean technologies and advanced manufacturing.

Along with the remarkable investment in industry has been the tangential redevelopment of dozens of historically significant and architecturally outstanding buildings by Frank Lloyd Wright, H.H. Richardson, Louis Sullivan and Louise Blanchard Bethune, to name a few. Long overlooked and underused, today these gems are being revitalized as high-end luxury condominiums, affordable and attractive student housing, Class A office space, hotels, legal and financial services offices, high-tech incubators and shared workspace setups, restaurants, retail and more. A redevelopment strategy supporting public-private investment is being led by the Buffalo Building Reuse Plan and implemented by the Buffalo Urban Development Corporation.

Businesses opening in or relocating to Buffalo are consistently impressed by the trained and educated workforce they find. The region also offers reasonable business development costs and easy access to major markets like New York, Chicago, Boston and Toronto without the hassles or high costs of locating in major metropolitan areas. And once in Buffalo, people are amazed to discover Buffalo’s affordable housing, temperate climate and outstanding quality of life.

In the last decade, brownfield redevelopment and innovative reuse projects have resulted in renewed access to the waterfront, including Canalside—a waterfront park and public space at the original terminus of the Erie Canal. Here, hundreds of thousands of people gather throughout the year to enjoy concerts, festivals, boating, museums, shops and restaurants—and all within the first five years of Canalside’s groundbreaking.

Inspired by the activity at Canalside and the passion of Western New York sports fans, the National Hockey League’s Buffalo Sabres are building a $172 million, best-in-class facility to showcase both minor league and amateur hockey events right next to the Sabres’ home at First Niagara Center.

And there are meaningful investments in Buffalo’s arts, cultural and educational institutions, too. Within the last five to seven years, residents and visitors have been able to enjoy the revitalization of the Buffalo Zoological Gardens and the Buffalo Olmsted Parks system, the opening of the Burchfield Penney Art Center (the first new museum in the city in more than 100 years), and the reconstruction of the entire Buffalo Public Schools system. In addition, several other cultural venues, including the world-renowned Albright Knox Art Gallery and Explore and More Children’s Museum, are building, expanding or renovating.

In 2012, New York State Governor Andrew Cuomo pledged $1 billion in state funding to support investment in key industries in Buffalo Niagara to leverage an additional $5 billion in private investment. To achieve this goal, Buffalo’s business executives, government officials and community leaders are working together to implement a strategic and focused plan to invest in life sciences and health care, education, culture and tourism, and high-tech manufacturing. This state-level investment means that new and relocating businesses will get the support they need for their companies to take root and grow. And, thanks to Buffalo Niagara’s geography—within the largest freshwater basin in the world and surrounded by two Great Lakes and the mighty Niagara River—the region is uniquely positioned to support forward-looking energy production, like wind and solar energy, and to supply inexpensive hydroelectric power to new and expanding manufacturers in Buffalo Niagara.

Buffalo is a decidedly different place than it has been for the last 50 years—and there are more than four billion reasons why. For more information visit Buffalo Niagara Enterprise at www.buffaloniagara.org or call 800-916-9073.

The post LOCATION FOCUS: United It Stands appeared first on Business Facilities.

(Photo: Heidi Schwartz)

Posted by Heidi Schwartz

The New York City Regional Economic Development Council (NYCREDC) and NYC SeedStart have announced “NYC SeedStart Enterprise 2013,” a startup focused accelerator program in New York City. The initial program will target entrepreneurs tackling enterprise solutions and provide resources and opportunities for the entrepreneurs to collaborate with one another, discuss problems and challenges, and build the next generation of enterprise technology. NYC SeedStart Enterprise 2013 is part of a series of six business accelerator programs moving forward on the strength of a $550,000 award from Governor Andrew M. Cuomo’s Regional Council initiative, as well as corporate partners CA Technologies, Deutsche Telekom and others.

Applications for the program must be submitted by May 5. The program will begin July 8 in New York City and conclude with presentations to investors in September.

“New York City is the place to be for entrepreneurs with innovative ideas looking to create the products of tomorrow,” said Matthew Goldstein, Chancellor of the City University of New York and NYCREDC Co-chair. “The NYCREDC identified the NYC SeedStart program series as one of its priorities because it is exactly what we need to grow early stage startups into job-creating companies. We are very pleased to partner with NYC SeedStart and look forward to seeing the new products and companies that result from this collaboration.”

“We have brought together a unique group of industry, city and entrepreneurial mentors in order to help grow the next big enterprise companies here in NYC,” said Owen Davis, Managing Director of NYC Seed and founder of NYC SeedStart. “We want to see the ideas developed by New Yorkers transformed into new companies that stay, grow and lead the new economy in New York. This summer’s program will launch the next generation of entrepreneurs, and we commend the State and all of our partners for their support.”

The NYC SeedStart accelerator program series strongly aligns with the NYCREDC’s economic development strategy and was identified as a priority project. As a result, NYC SeedStart was awarded a $550,000 grant from Empire State Development to support six 12-week business accelerator programs to foster the growth of startups in New York City. NYC SeedStart Enterprise 2013 will receive a portion of the grant funds and the balance will provide continued support to future accelerator programs.

“For far too long, innovative and transformative new ideas have been developed in New York only to be exported and commercialized in other states,” said Empire State Development President, CEO & Commissioner Kenneth Adams. “Under Governor Cuomo’s leadership, we are working harder than ever with partners like NYC SeedStart to connect startups with corporate partners that can turn concepts into products, which will grow new businesses and create jobs at home in New York. The NYC SeedStart Enterprise 2013 program will develop the next generation of high-tech companies that we need to continue growing our economy and remain at the forefront of the 21st century global economy.”

The vertical focus of NYC SeedStart Enterprise 2013 is “uniquely New York,” involving numerous corporate participants working collaboratively to foster the growth of new startups in New York State and bridge the gap between large enterprise corporations and early stage startups that are developing new technology to transform the industry. Future NYC SeedStart programs will focus on other industry verticals. The NYC SeedStart consortium includes NYC Seed, Contour Venture Partners, RRE Ventures, StarVest Partners and Safeguard Scientific.

The intensive, 12-week program is designed to help entrepreneurs focused on the next-generation of enterprise software launch new ventures in New York City. New York City has become one of the leading entrepreneurial eco-systems in the country. With access to large amounts of capital, highly experienced investors and a robust ecosystem, New York is a very attractive location for companies to launch. The goal of NYC SeedStart Enterprise 2013 is to establish an infrastructure that will enable talented entrepreneurs to work on important enterprise trends and products in New York City and launch their ventures.

Startup companies accepted into the program will have direct access to senior level executives from partnering firms and receive $20,000, as well as mentorship and workspace. In addition, startups selected for the program will also receive support from an outstanding group of venture capital firms including Contour Venture Partners, NYC Seed, RRE Ventures, Safeguard Scientifics and StarVest Partners, as well as many notable entrepreneurs and Empire State Development (ESD), Silicon Valley Bank and the law firm of SorinRoyerCooper.

The growing number of new enterprise software companies in New York City over the last several years has led to a stream of new innovations that the leading enterprise companies are eager to grasp. Startups will benefit from the advice and possible partnership with their larger counterparts, while participating corporations will have exposure to the cutting edge technology and ideas created during the course of the program.

Maria Gotsch, President and CEO of the Partnership Fund for New York City said, “New York City is a key market for enterprise technology given the extensive number of large corporations operating here. Through the Enterprise 2013 accelerator and with the Partnership Fund’s help, NYC SeedStart will provide both capital and access to key corporate relationships to catalyze the growth of the next generation of enterprise tech companies and associated jobs in New York City.”

Russell M. Artzt, Vice Chairman and founder, CA Technologies said, “I am excited to participate in the NYC SeedStart enterprise program. We look forward to working with entrepreneurs that are trying to build innovative enterprise companies and supporting the entrepreneurial ecosystem in New York. Hopefully our mentorship will lead to some strategic partnership discussions with CA Technologies.”

Stuart Ellman, Co-Founder and Managing Parner of RRE Ventures said, “At RRE, we see the need and the tremendous potential for an enterprise incubator such as NYC SeedStart. We are proud to be a supporter and look forward to working with the companies.”

Andreas Wuerfel, Director Innovation & Technology Scouting Deutsche Telekom, Inc. said, “At Deutsche Telekom we embrace and value the power of innovation. It is exactly programs such as ‘Enterprise 2013’ that help foster that vital dialog between New York’s entrepreneurs and corporate organizations. We look forward to participating in this year’s program and are excited to help shape potential win-win strategic opportunities.”

Among the hundreds of companies applying to be a part of the program, NYC SeedStart Enterprise 2013 is seeking companies building new technology in SaaS, real-time analytics, security, cloud services, and consumerized enterprise products.

For more information about NYC SeedStart Enterprise 2013, visit www.nycseedstart.com. Inquiries should be directed to Brian Malkerson at info@nycseedstart.com.

The post NYC Regional EDC, NYC Seedstart Announce Enterprise 2013 Startup Accelerator Program appeared first on Business Facilities.

Since we’ve attended the big BIO show for years, we noticed some subtle differences in this year’s confab, which wrapped up yesterday in Chicago.

It’s hard to ignore the fact that the show is getting smaller: some key state exhibitors as well as a significant number of attendees have taken it off their agendas. But while some states are dropping out, the international contingent keeps getting larger. A big new booth from Russia and a much larger presence from China were notable in Chicago (and we thank our Russian friends for installing the most comfortable couches on the show floor).

BIO also continues to be a magnet for some of our leading governors. Among the state chief executives we ran into trolling the show floor in Chicago were Missouri’s Jay Nixon (who was touting a big new deal with Monsanto), Wisconsin’s Scott Walker and Rick Perry of Texas. Gov. Perry landed on the front page of the Chicago Tribune when he suggested that Illinois businesses would be better off if they moved to the Lone Star State.

The main spotlight at BIO was reserved for Pennsylvania Gov. Tom Corbett, who was honored as BIO’s 2013 Governor of the Year in recognition of his commitment to strengthening the biotechnology and public health sectors.

Jim Greenwood, president and CEO of BIO, presented the award to Gov. Corbett, stating that his administration has “developed and promoted some of the industry’s best programs and standards, helping Pennsylvania stand tall among our nation’s greatest biotech hubs.”

“By enhancing the business environment to support the capital intensive processes of research and development as well as growing innovation companies facing significant start-up costs, Governor Corbett is creating an environment favorable to business and R&D. He’s positioning Pennsylvania as a valued leader within the industry,” Greenwood said.

“This recognition from the Biotechnology Industry Organization acknowledges the relentless effort my administration is putting forth to strengthen and further build the life sciences industry in Pennsylvania,” said Gov. Corbett. “By supporting initiatives that stimulate growth within the industry – from helping entrepreneurs quickly transform ideas into commercial products to supporting the establishment and expansion of biotech companies – we are ensuring the biotech economy will continue to grow and flourish in Pennsylvania. We are proud to continue to serve as a national leader of how to unlock the best of what the life sciences industry has to offer.”

“We at Pennsylvania Bio are thrilled that Governor Corbett’s efforts to help build a sustainable state-wide biotech community are being recognized by BIO,” said Chris Molineaux, President of Pennsylvania Bio.

“By assembling a task force of industry, academia, trade organizations and the legislature through the Life Sciences Leadership Advisory Council, Governor Corbett has shown his long-term commitment to implementing policies that enable organizations to obtain the resources required for establishing and building a strong biotech economy,” Molineaux added. “Additionally, the ‘Discovered in Pennsylvania, Developed in Pennsylvania’ program has helped local organizations establish and anchor their operations in the Commonwealth and his support for expanding access to capital has helped emerging firms make their novel advancements possible.”

Business Facilities congratulates Gov. Corbett for a job well done as BIO’s 2013 Governor of the Year.

Note: There is a poll embedded within this post, please visit the site to participate in this post’s poll.

The post Governors March Into BIO appeared first on Business Facilities.

Lt. Gov. Kim Guadagno, State of New Jersey

By the Business Facilities Staff
From the March/April 2013 issue 

BF: Amazon has announced it will build a $200-million fulfillment center in Robbinsville, the first phase of a major investment in NJ. Do you anticipate that central New Jersey will be a major logistics hub?
KG: Yes, I believe central New Jersey and the state as a whole will continue to develop as a major logistics hub. With more than 38,000 miles of interstates and highways, nearly 1,000 miles of rail freight lines and the nation’s third largest seaport—not to mention access to 130 million consumers within a day’s drive—New Jersey is already a leader in transportation and logistics. Central New Jersey is a great location for companies that need access to world-class infrastructure and transportation networks.

BF: The University Heights Science Park in Newark is gaining international attention, with Biotrial of France establishing its North American headquarters there. What role do Newark’s five universities play in attracting new biotech players to the state’s largest city?
KG: The Science Park is focused on drawing in technology companies that specialize in biosciences and biotechnology, information and communications, environmental and energy technology and advanced manufacturing technology. Home to 35,000 university students, researchers and professors, the research taking place and the highly skilled workforce being trained in New Jersey are the forces behind attracting new global biotech companies to Newark and to New Jersey. The state public research universities that are involved in Science Park—University of Medicine and Dentistry of New Jersey (UMDNJ), Rutgers-Newark and New Jersey Institute of Technology (NJIT)—annually conduct nearly $100 million of research, most of which takes place at their sponsored technology centers in Newark’s University Heights district. Additionally, Essex County College focuses on training the technicians in 11 science and technology fields.

BF: Gov. Christie recently signed the Angel Investor Tax Credit Act, which is aimed at spurring early-stage biotech investment. How does the program work?
KG: The law encourages investment in technology companies by providing a tax credit against corporation business and gross income taxes of up to 10 percent of the qualified investment, up to a maximum of $500,000 per year for each investment. The program is subject to a $25 million annual cap. To be eligible, companies must have fewer than 225 employees, with at least 75 percent of those jobs within New Jersey, and must conduct research, manufacturing or technology commercialization in the state.

BF: Data storage leader CommVault is putting its global headquarters in Fort Monmouth. Are other companies considering locating at the Fort Monmouth site?
KG: At the end of January, the State reached a significant milestone in the redevelopment of the former military installation when the first sale of property was finalized between the Fort Monmouth Economic Revitalization Authority (FMERA) and CommVault. The global technology leader plans to undertake a three-phase project on the 55-acre site in Tinton Falls, including a 275,000-square-foot facility to serve as its worldwide corporate headquarters. Once the three phases of the project are completed, CommVault may create a total of up to 1,500 new jobs in NJ. In addition to CommVault, AcuteCare Health System is also expected to soon call the former Fort home. The company plans to reuse the former clinic as a medical facility, creating 50 new jobs in the near-term and investing a minimum of $5 million. AcuteCare is a privately owned corporation formed in 2002 to establish and manage long term acute care hospitals.

BF: How is the FMERA working to spur development at the former Army base?
KG: The Fort Monmouth Economic Revitalization Authorization Act is creating an environment where companies can invest and employment can grow. FMERA is responsible for filling the 1,127 acres of land, with a focus on attracting technology-based companies. Master broker Cushman & Wakefield continues to leverage the work of FMERA to market the former Fort Monmouth property to attract businesses and investors. The Cushman & Wakefield team established www.fort-monmouth-marketing.com to showcase the property.

BF: NJ purchased billboards at the Super Bowl and President Obama’s inauguration for its “Resilience” campaign. What is the key message of this campaign?
KG: The key message of the “State of Resilience” campaign is that New Jersey is open for business, despite being hit by Superstorm Sandy in October. The objective of this integrated marketing campaign is to share this message with corporate decision makers in targeted top markets, while reassuring companies already invested in the state. New Jersey still remains a prime location for business, and it’s our job to let the world know that. And it’s important to note that not a single tax dollar was spent on this campaign, which is being led by Choose New Jersey, Inc., the state’s nonprofit business recruitment agency in partnership with New Jersey’s private industry sector.

BF: What are the most important steps NJ is taking to improve its business climate?
KG: New Jersey is equally dedicated to attracting new jobs and investment while retaining the businesses that are here. It’s important for us to promote New Jersey’s business advantages nationally and internationally. To do this, we meet with companies across a range of sectors, as well as with site selection consultants to update them on NJ’s business value proposition. In 2010, we created the Partnership for Action. This organization is made up of the New Jersey Business Action Center, the New Jersey Economic Development Authority and Choose New Jersey, Inc. Since its inception, the Partnership for Action has worked with the state government to generate a projected 64,056 new and retained jobs and more than $9.8 billion in capital investment. We also have worked with policymakers on lowering taxes, adopting a single sales factor, eliminating or streamlining the red tape and bureaucracy, and restructuring government to make it easier for our businesses to grow, while also recruiting new businesses to NJ. The bi-partisan Red Tape Commission has succeeded in removing dated regulations, fostering the use of online technology to streamline licensing and permitting applications; it continues to review the state’s regulatory process to remove obstacles that impede growth.

All of these organizations continue to work together to find new ways to improve our economy and market our key messages, so that every company knows what we can do for them in New Jersey.

The post SNAPSHOTS: 60 Seconds…with Lt. Gov. Kim Guadagno, State of New Jersey appeared first on Business Facilities.

Scripps Research Institute in Palm Beach, FL

By Stefanie Ramsperger and Jack Rogers
From the March/April 2013 issue

The recovery in the biotech sector appears to be solidifying. According to the most recent biotechnology report published by Ernst & Young, the sales in established biotech markets grew more than 10 percent in 2012. This threshold hasn’t been crossed since the outbreak of the worldwide financial crisis. Expenditures for research and development significantly increased by 9 percent.

About $33.4 billion in venture capital was raised in the sector. However, mostly big enterprises profited from this inflow whereas small- and medium-sized companies still have to suffer from a depletion of seed money since the Recession. In contrast to the U.S., financing in Europe has not regained the levels seen prior to the financial crisis. A retreat in the public markets in 2011 resulted in overall financing levels that are back to those seen in 2008, reflecting the continuing struggles of the Eurozone countries over the sovereign debt of some member countries.

While the biotechnology sectors of Eurozone countries are relatively small, the uncertainty has driven investors across the continent to seek lower risk. One bright spot is that, similar to the U.S., Europe has seen venture capital hold relatively steady. Across Europe, there were 56 venture rounds of greater than $5 million (down from 65 in 2010). The most significant venture capital transactions included $39 million raised by Symphogen (Denmark), $99 million raised by Biocartis (Switzerland) and $96 million raised by Circassia (United Kingdom). Biotech accounts for approximately 15 percent of total venture capital investment across Europe, a slightly higher percentage than in the U.S. in 2011.

In Europe the list of commercial leaders—Actelion, Elan Corp., Eurofins Scientific, Ipsen, Meda, Novozymes, Qiagen and Shire—has not changed since 2007. In 2011, the revenues of these commercial leaders increased by 19 percent, while those of the other companies decreased by an identical percentage. The same pattern was repeated across all the major indicators, with the health of a few large companies increasing as the rest of the industry saw its performance worsen.

In this year’s Global Biotech Report, we zero in on several locations in Europe that are well-positioned for future success, including three biotech hubs in Germany and key biotech/ pharma centers in Austria, Belgium and Luxembourg that have strengthened their competitive position in the global market in recent years. As always, we also take a fresh look at the leading biotech and pharmaceutical hubs in the U.S.

Hessen Keeps Getting Bigger In Biotech/Pharma

Biotech is among the most important sectors of the Hessen region and this sector is growing every year. With Frankfurt recognized as the financial capital of Germany, the area is well known for its excellence in the service sector. However, the region also excels in manufacturing industries, and it is Germany’s logistics gateway to the world.

More than 19,500 people are employed in the biotech/pharma sector in Hessen. The area has 225 biotech companies (of which 59 are core biotech concerns), and 14 percent of these employ at least 500 people. In the last decade, Hessian biotech companies have more than doubled their revenues to over 5.2 billion Euros.

The strength of Hessen’s biotech sector are a multitude of R&D programs, its number of industry patents and its domination in the medical sector of biotechnology—known as “red” biotech, accounting for 81 percent of all Hessian biotech revenues (according to the latest Location Study Hessen-Biotech, which was commissioned by Hessen’s location marketing organization, Hessen Trade and Invest GmbH). However, industrial biotechnology (“white” biotechnology) is on the rise. About 56 percent of all biotech companies in Hessen have their own R&D programs.

White biotechnology is located at the interfaces of chemistry, biology and the engineering sciences. “It uses microorganisms and enzymes to create new substances and processes for the purpose of producing innovation for many different user sectors, for example amino acids, vitamins and aromas for the food industries,” explains Dr. Thomas Niemann, Director Technology and Future at Hessen Trade and Invest GmbH.

The biotech/pharma activities in Hessen center around two clusters: one is located in Central Hessen, the other is in the southern part of the State. Hessen is a stronghold in biotech production. Out of a total capacity of more than 830,000 liters of fermentation production in the manufacture of “red” biotech in Germany, more than 250,000 liters are attributed to Hessen. Production takes place in Frankfurt (sanofi-aventis), Marburg (Novartis- Behring), and Hanau (Heraeus).

Höchst Industrial Park in Frankfurt is one of Europe’s largest chemical and pharmaceutical parks and looks back to almost 150 years of chemistry tradition. Just in 2012, tenants invested 310 Million Euros, bringing the total to about 5.5 Billion Euros since 2000. Höchst hosts 90 on-site companies, among them sanofi-aventis, Bayer CropScience, Clariant and Celanese. Researchers, manufacturers, customers and service providers come together at the site and cooperate in terms of raw materials and infrastructure. They also join forces with regard to future-oriented technologies, because the Industrial Park embodies a wealth of research and production know-how. Site operator Infraserv Höchst offers services with regards to secondary processes; for example, they provide the companies with raw materials on-site, do the facility management and run site security. New companies can also rely on their patent lawyers, engineering consultants and other personnel services, which decreases their starting cost.

Hessen has five universities and five Schools of Applied Sciences that cooperate with biotech companies. Hessen is particularly strong in the field of Medical Technology. It comprises a total of 900 medical tech companies, which employ more than 20,000 people. Many of them are located at Höchst Industrial Park. According to Dr. Niemann, “one-third of the German production capacity of biotechnological medicine is centered in Hessen.”

Recently, the importance of “white” (industrial) has increased in the area. The Cluster Initiative Integrated Biotechnology (CIB) in Frankfurt supports networking in this field. The cluster was one of the winners of the “BioIndustry 2021” contest held by the Federal Ministry of Research. The Hessian state government also has set up a state initiative for the Development of Scientific and Economic Excellence (LOEWE) with the aim of providing long-term support for the research landscape. “This especially includes new ideas in Industrial Biotechnology,” says Niemann. “In Hessen, funds of more than 32 million Euros are made available for Industrial Biotechnology.”

Another promising biotech field is “personalized medicine.” CI3 is a network in Hessen to advance individualized immune intervention. It has been selected as one of Germany’s leading edge clusters in 2012 and has thus been awarded 40 million Euros by the German government. “Research in this field is very promising,” confirms Niemann. “The cluster, that is supported by the states of Hessen, Rhineland-Palatinate and Baden-Wurttemberg and has 120 member-institutions, is on its way to the very top.”

The cluster CI3 works on innovative medicine that is exactly adjusted to the individual patient, who suffers, for example, from tumors or autoimmune diseases. The center of the cluster is based in Mainz. The idea of the cluster is that companies and research facilities will work in partnerships on 78 different projects. The project partners estimate a total volume of approximately 130 million Euros.

“Universities, other research facilities, small and medium-sized companies as well as international players in the field—we have the whole value chain in Hessen,” says Thomas Niemann. Among the project partners are, for example, the technical university Darmstadt, Goethe University Frankfurt, the Paul-Ehrlich-Institution, Georg-Speyer-Haus, Abbott, Biotest, sanofi-aventis and Merck.

Berlin: Biotech Mega-Hub

The Berlin-Brandenburg region concentrates on clinical research. In the capital of Germany, biotechnology is a strong force driving innovation and growth, interfacing with the pharmaceutical, diagnostics and medical technology sectors. Berlin-Brandenburg has a versatile research and clinical landscape. HealthCapital, the cluster management of the region’s healthcare industries, was implemented in 2010. Its goal is to coordinate companies, research and education institutes to foster collaboration and innovation.

Among the focus areas of Berlin-Brandenburg are biomedicine and diagnostics, therapeutics and regenerative medicine and industrial biotechnology. Berlin-Brandenburg is home to more than 200 biotech companies. The sector employs more than 4,000 people. In addition, pharmaceutical and medtech companies in the area have another 10,000 employees each.

Like Munich, Berlin is a top location for start-ups. In 2012, Berlin was ranked the top start-up region in Germany by Foreign Direct Investment magazine. The region offers foreign companies reimbursement grants of up to 50 percent. Berlin is not only home of various start ups, but existing bioscience companies are expanding in the area. In 2012, Takeda made Berlin its distribution headquarters. The Japanese pharmaceutical company is Berlin’s most recent arrival, having relocated its distribution unit from Aachen and Konstanz to Berlin.

Also, sanofi-aventis and B. Braun Melsungen made large investments to expand their existing locations in Berlin. B. Braun Melsungen had their roofing ceremony in January 2013. The 38.2 million Euro expansion project increases the size of the production site by 65 percent. Injectable solutions in plastic containers will be manufactured there. The building will probably be completed by October 2013. Production lines will be installed in 2014. B. Braun Melsungen expects to create 25 new jobs by 2015.

In the past five years, B. Braun Melsungen already had invested 40 Million Euros in Berlin for expansion projects. 670 employees already work for the company in Berlin. In total, the business has three sites in Germany’s capital.

Among other major global corporations that are located in the capital region are Bayer Pharma AG, Berlin-Chemie AG, Pfizer Deutschland and sanofi-aventis. In the past years, sales revenues of more than 5 billion Euros were generated by pharmaceutical products of 24 Berlin-based pharma companies. Together, they employ 10,000 people in the area.

Among a variety of research institutes in Berlin that focus on Life Sciences are four Max Planck institutes, two Fraunhofer institutes, Leibniz institutes and Helmholtz centers, five universities and four universities of the Applied Sciences.

The Berlin Institute of Health (BIH) was founded in November 2012. On this occasion, Professor Walter Rosenthal, chairman of the board and scientific director of the Max Delbück Center for Molecular Medicine Berlin Buch, said: “The founding of the Berlin Institute of Health is a unique opportunity for the German science landscape to restructure the collaboration between a non-university research institution and a university medical center in the field of basic and clinical research.” The BIH will be established in 2015 by the state of Berlin as a public corporation and it will combine the research of the Charité and the MDC, one of 18 research institutions of the Helmholtz Association. The MDC employs more than 1,600 people from 57 countries and works with a budget of more than 70 million Euros per year. The goal is that the cooperative venture with the Charité will harness the strengths and expertise of both partners and significantly advance health research not only in Germany but also on an international level. It will focus on an interdisciplinary approach. For research of the BIH in the coming years, extensive technology platforms are being setup.

“Based on its excellence in interdisciplinary and transnational cooperation, the cluster HealthCapital Berlin- Brandenburg is generating innovations which are to benefit patients as soon as possible,” says director BioTOP Berlin-Brandenburg and cluster manager HealthCapital, Dr. Kai Bindseil. “The application spectrum for biotechnology is constantly increasing. While biotech has concentrated on developing new medicine and diagnostics in recent years, we are now moving on to new markets due to intelligent interconnections with branches like information and communication technology.”

To enforce cooperation at the interface of biotech and IT, Berlin brings together IT and biotech science and industry to develop interdisciplinary projects for innovative IT-supported healthcare. One example is the project “IT-Future of Medicine (ITFoM). The Max Planck Institute for Molecular Genetics is leading in the project. 60 institutions and companies have joined forces to develop computer models by which personalized “virtual patients” will be derived from the molecular, physiological, anatomic and environmental data of every individual patient. The goal is to develop optimal concepts with minimal side effects.

Public support remains an important factor for financing new products because only few companies have access to venture capital funding. A study by Fleischhauer, Hoyer & Partner has shown that venture capital has increased compared to the crises. With 70 million Euros most of the money was invested in biotech. Investments in medtech were also high with 66 million Euros. The study shows that the Berlin-Brandenburg area ranks third (Bavaria and North Rhine-Westphalia rank first and second) in regional distribution of all investment. According to the latest BioTOP Report, public funds worth up to 42 million Euros are provided by the federal states for fixed-asset investments and new product developments. The leverage effect generated a further 45 million in private investment. The federal government and the European Union provide additional double-figure million Euro funding.

For start-ups, the High-Tech Gründerfonds (HTGF), leading investor in innovative start-ups, has created a new fund worth more than 300 million Euros. Among the investors are Altana, BASF and Robert Bosch.

From Invention To Innovation In Bavaria

“Success through synergies” is the motto of the Bavarian cluster initiatives. To assist entrepreneurs in the starting up and expanding of biotech, Bavaria has set up three agencies under the cluster Biotechnology Bavaria: BioM is responsible for greater Munich, BioMed Würzburg is located in the north of Bavaria and BioPark Regensburg GmbH is responsible for biotech in the core of the state. Bavaria is home to over 320 biotech and pharmaceutical companies.

The cluster in the greater Munich area is home to around 200 companies. 19,000 employees work in the Munich Biotech region. With two universities, two universities of Applied Sciences, the Max Planck Institute of Biochemistry, Neurobiology and Psychiatry and the Helmholtz Research Center for Environmental Health, the region offers an excellent environment for innovation. These institutes include, for example, the Center for Nanosciences, which is one of the world’s leaders in the development and application of nanobiologies. The Life Sciences Campus in Martinsried forms the core of Munich’s Biotech region. The agency “Invest in Bavaria” states: “The campus is home to nearly half of the region’s Biotechs.”

IZB – Biotech Incubator Martinsried Bavaria

The focus of this area is on “red biotechnology,” particularly on diagnostics and therapeutics. The region is dominated by small and medium-sized companies, but eight corporations are listed on the stock exchange, among them MorphoSys.

Freising, located just a few minutes north of Munich, is home of the Weihenstephan campus. It is one of Europe’s major centers of green biotechnologies and has its own incubation center.

In 2012, BioM announced that the Bavarian Ministry of Economics granted four groups of young academics in the field of biosystems research. The subsidies by the state mount up to 1.5 million Euros for each team of young academics. The duration for the grant is five years. This lays the cornerstone for a new research network in the field of molecular biosystems (BioSysNet) that is being established within the framework of a new strategy called “Aufbruch Bayern.” The four young academics that lead the research groups have previously worked in Italy, the Netherlands, Switzerland and in the U.S. The goal of BioSysNet is to further strengthen Bavaria’s competitive situation in molecular biosystems.

BioSysNet is part of a Bavarian research center for molecular biosystems and thus profits from the subsidies by the Ministry of Science, Research and Arts and is being supported by “Aufbruch Bayern.” The total subsidies amount to 18.1 million Euros.

Bavaria’s north attracts entrepreneurs in the field of biotechnology and medical technology with its Innovation and Start-up Center for Biotechnology and Biomedicine. The Würzburg region is the largest entrepreneurship center in the district of Lower Franconia. The project “Life Sciences in Würzburg” has been established to provide consultancy services and to promote start-ups.

A third hub for biotechnology in Bavaria is in the middle of the state, in Regensburg. Back in 1998 the BioPark Regensburg GmbH was founded. The industrial park was supported by the State of Bavaria and built directly on the university campus at a total cost of 42 million Euros. The park has been expanded in 2001, 2006 and 2011 and now offers 18,000 square meters of laboratory, office and storage space for companies and institutes. Currently, 36 leaseholders and 550 employees have chosen the BioPark. The Regensburg region is home of 47 companies with more than 3,145 employees, 900 of them working in the core area of biotechnology. This makes the Regensburg area the second top biotech region in Bavaria.

The specialties of the university of Applied Sciences in Regensburg are fluorescent bioanalytics, molecular diagnostics, biofunctional surfaces, sensors and applied biomedicine.

In January, BioPark Regensburg GmbH announced that a new center for biomedical engineering will be established in the area. The “Regensburg Center of Biomedical Engineering” (RCBE) will move into interdisciplinary lab facilities in Regensburg’s BioPark. The aim of the new center is to bundle biomedical, medical, IT and engineering competencies and make use of the interfaces.

It comes as no surprise that Regensburg bundles its competencies in interdisciplinary research. For four years the University of Applied Sciences in Regensburg has offered classes in “Medical Information Technology.” Since 2011, “Biomedical Engineering” is a course of studies. Graduates are qualified to work at the interface of medicine and IT, or engineering, respectively. The RCBE will now support and bundle research competencies in these fields. Its focus will be on biomechanics, e-health and equipment technology for medical engineering.

Collectively, companies in Bavaria have performed well in the past years. Employment figures rose slightly by two percent. Bavaria’s 166 small and medium-sized core biotech companies employed a record-setting 4,000-plus  people in the state. Since 2006, employment in these companies has grown by 30 percent. 126 of the 166 small and medium-sized companies are located in the greater Munich area. Core biotech companies account for 10,300 in Bavaria, a plus of 300 employees at Roche, Penzberg, which is remarkable. Adding pharma to this count brings employment in the sector to well over 20,000 people.

There were four newly established companies and among the most recent openings of international subsidiaries are three US-biotech companies and one Japanese pharmaceutical company. LabPMM, San Diego California, opened its German diagnostics Laboratory and Myriad Genetics, Salt Lake City, Utah, set up its central European laboratory in a new building in Martinsried.

Bavaria was countrywide the only state in the past year to attract foreign companies for greenfield development. Bavaria was able to chalk up about 70 million Euros of external biotech funding for Germany in 2011. Numbers for 2012 are not available yet, but it can be estimated that external funding will be higher after a rather meager year. At the same time, revenues of Bavarian biotech companies went up to a new record of more than 510 million Euros.

In 2010, the Munich Biotech Region along with Bavaria’s Medical Valley Nuremberg were winners of the Leading Edge Cluster competition by the German Federal Ministry of Education and Research. Until March 2015, the main research and development strategy for several projects in the Munich area will push personalized medicine. Like the cluster CI3 in Hessen which got the same award only two years later in 2012, the Federal Ministry of Education and Research contributes 40 million Euros for the cluster. The Munich Biotech region received another 60 million Euros by the Bavarian ministry and industry partners.

Next to this, a number of Bavarian biotech companies receive grants by the European Union for their research and development projects. One example is the EUROCALIN Consortium, which includes ten companies, for example Pieris AG in Freising. Over the last 15 years, Roche has invested more than 2 billion Euros for their location in Penzberg to develop and produce therapeutic proteins. In the last two years alone, they invested more than 350 million Euros in new plants for production of therapeutics and diagnostics in Penzberg.

Belgium: Beehive Of Biotech

In Belgium, Flanders has specialized in plant biotechnology, whereas Wallonia has focused on health biotechnologies and medical technologies. Most biotech companies in Belgium are located in the northern part of the country, Flanders. Approximately 17 percent of the companies are in the Capital region, and Wallonia is home to around 34 percent of the companies.

More than 15 percent of the European biopharmaceutical exports come from Belgium. The country is said to be the largest exporter in pharmaceutical goods. A quarter of the world’s vaccines are produced in Belgium. As the world’s second largest vaccine producer, the company GlaxoSmithKline (GSK Biologicals) in Rixensart, southeast of Brussels, contributes to a great deal to this. Approximately 30,000 people work in the biotech sector.

Biotech in the three parts of Belgium is organized in special associations. Flander’s association is called “FlandersBio,” the association in the Capital Region is called “Brussels Life Tech” and Wallonia’s association is “BioWin.” Flanders in the North looks back to a strong tradition of biotechnology that is centered around the university towns of Gent, Mechelen and Leuven. Flanders is home to more than 120 biotech companies, most of which belong to the health and green biotechnologies sectors.

Brussels is home to mostly young biotech companies. Although the region covers not even one percent of the country’s territory, it represents more than 15 percent of the biotech activity in Belgium. Most companies in the capital work in medical biotech.

The same holds true for companies in Wallonia. Since 2005, the regional government of Wallonia supports biotechnologies with the so-called “Marshall Plan.” Setting out from this action plan, the Walloon government has updated and optimized its priorities via a “Marshall Plan 2.Green.” It has been endowed with a budget of 2.75 billion Euros for the period 2009 to 2014. 1.15 billion Euros are alternative funding.

One of the most important regional clusters is the “BioWin” life science network. 27 research and development projects are being funded within the cluster. “BioWin is establishing Wallonia as a world leader in various areas of cutting-edge technology, such as biopharmacy, cell therapy, radiopharmacy, diagnostics, biotechnological products for research and industry, bioinformatics and the processing of complex data,” says Frédérick Druck, communication and international relations director at BioWin.

The cluster has 510 members with 116 businesses and around 80 percent of its members are small and medium-sized companies. 400 research units employ about 11,000 researchers from five academic centers of excellence. With 14,300 employees and a turnover of 4.4 billion Euros, the health sector is key to the economy of Wallonia.

Of the 27 projects that have been funded as a result of the Marshall Plan, five have been completed. Druck says: “In the coming years, we will create 1,200 new jobs.” He adds: “With the help of the cluster we have made a big step in excellence in technologies.” One outcome of this is that 51 patents connected to the projects have been submitted and seven new products have been launched on the market. “We see that five new businesses have been set up,” Druck adds. “Now that there is a network there is a real dynamic.”

Internationalization is key to BioWin in order to strengthen its global competitiveness. Therefore, WAL-Dx/BioWin, the Walloon in vitro diagnostic network and its partner, EuroMediag, the diagnostic cluster of EuroBioMed, the health cluster for the PACA and Languedoc-Roussillon regions (France) joined forces to create EDCA, the European Diagnostic Cluster Alliance. The network already includes nine clusters and represents 400 companies and 40 universities across Europe.

“It was also important for us to create new technological platforms,” Druck says. MaSTherCell, Wallonia’s first technological platform dedicated to the clinical and commercial production of cell therapy products for third parties is a case in point. Realized in 2011, it helped create 20 new jobs. By 2014, 35 jobs will be created and 50 new jobs are predicted by 2017.

“In Wallonia, the universities in Brussels, Charleroi and Liège are hotspots for research,” says Druck. In total, 14 universities and several other research facilities add to Belgium’s great research experience. Flanders and Wallonia have five universities each and four schools are located in the Brussels area. On a regular basis, Belgium’s universities rank among the top 25, according to the Academic Ranking of World Universities. Leuven University, for example, has specialized on medicine, cell biology and gene therapy. Gent University, by contrast, focuses on biomedicine and plant genetics. Hasselt University is known for its expertise in autoimmune diseases.

The financial situation for biotech companies in Belgium is favorable. “For the last eight months we note that very small companies have found 60 million Euros private capital at venture capital funds,” says Frédérick Druck. The website reports that Belgium is Europe’s leader with regard to venture capital.

One recent investment was made by the biopharmaceutical company Union Chimique Belge (UCB). The company inaugurated a new biotechnology pilot facility at the Braine-l’Alleud site of UCB in September 2012. The site operates a research and production facility employing 1,500 people. The biopharmaceutical facility was constructed with an investment of 65 million Euros. Approximately 100 new jobs will be created. With the opening of the pilot biotech center, UCB is gearing up to reinforce its biotech activity through industry and academia collaboration. It is among the first plants in Belgium to produce cell-culture-based therapeutic proteins. The plant is a milestone in the development of new biological medicines and molecular development.

Luxembourg: Europe’s Solid Rock

“[Luxembourg has] a solid foundation to generate future economic diversification and growth,” says Dr. Thomas Dentzer, Head of Life Sciences Sector Development and Luxembourg BioHealth cluster manager. As the competitiveness of a country is more and more dependent on effective innovation networks involving private and public sectors, Luxembourg has implemented various initiatives in order to strengthen the research and development and innovation potential of companies and to reinforce links with public research organizations and academia.

Luxembourg’s House of BioHealth

“The Luxembourg Cluster Initiative, launched by the Luxembourg government, actively encourages networking between the private and the public sectors,” explains Dentzer. Healthcare and biotechnology are among the key technologies that have been identified as being important for the future sustainable development of the Luxembourg economy. Luxembourg’s research and development and innovation policy brings together biotech with other networks, such as eco-innovation-technologies or IT.

The Luxembourg BioHealth Cluster brings together public and private stakeholders whose activities are related to health science and technologies in Luxembourg. “It aims to foster partnerships and collaborations that favor innovative projects, thereby reinforcing and capitalizing on the national strategy developed to achieve scientific excellence in molecular medicine,” says Dentzer.

Luxembourg is strong in biomedical research. “The trends in Luxembourg, also due to the focus on personalized medicine, are going in the direction of computational biology and bioinformatics, using the latest IT-solutions to investigate complex processes,” adds Dentzer. The medical field is taking advantage of Luxembourg’s IT infrastructure and its expertise in data security.

Among the most important research facilities in the Grand Duchy of Luxembourg are the Integrated BioBank of Luxembourg (IBBL), the Luxembourg Centre for Systems Biomedicine (LCSB) and, most recently, the House of Biohealth, a new life science incubator.

The mission of IBBL is to work with the people of Luxembourg to provide high quality specimens and data, catalyze partnerships and support research. To accomplish its aims IBBL will, for example, support the four priority research programs in the personalized medicine initiative (cancer, type 2 diabetes, Parkinson’s disease and normal population cohort). The LCSB, by contrast, is accelerating biomedical research by closing the link between systems biology and medical research. Neurodegenerative diseases like Parkinson’s disease, metabolomics and disease network analysis are in the focus of LCSB’s research.

Luxembourg’s most recent research facility is the House of Biohealth. The construction of the new life sciences incubator was officially launched in  November 2012 by the Secretary of Economy and Foreign Trade, Etienne Schneider. It aims to facilitate the transformation of research results into marketable products and services, and it is expected to receive its first tenants in the beginning of 2014. It will be built in the vicinity of the future city of sciences in Esch-Belval. Dentzer says: “This unique facility will offer office space as well as laboratories providing the necessary infrastructure for the creation and development of start-ups as well as already established companies in the fields of biotech, cleantech and ICT.” Within 10,000 square meters of laboratory space, the building is expected to host 500 to 700 researchers.

The building is a joint project of the Luxembourg Ministry of Economy and Foreign Trade, the ZARE Park for economic activities in Esch-sur-Alzette and private investors.

The Luxembourg government has developed financial aids for companies involved in research and development. The Ministry of Economy and Foreign Trade, for example, targets small enterprises or small private research organizations established in Luxembourg which were created less than six years before the aid is granted and which either will, in the foreseeable future, develop new products, processes or services, which involve a significant risk of technical or industrial failure or which have used at least 15 percent of their operating expenses for research and development over the least one of the three years preceding the granting of the aid, or over the current year. All of the enterprise’s expenses are eligible. This aid can only be awarded once and it cannot exceed one million Euros. Financial aids for new innovative businesses are, for example start-up loans or equipment loans offered by the Société Nationale de Crédit et d’Investissement. To support intellectual property rights, Luxembourg offers an 80 percent tax exemption to income from patents, trademarks, design, models and software copyrights or domain names. Capital gains generated on intellectual property will be exempt up to 80 percent. Plus, in 2009, net wealth tax was abolished on qualifying intellectual property.

Biotech company WaferGen Biosystems, Inc. set up its European headquarters in Luxembourg in 2010. The Luxembourg government provided the company with significant support towards increasing its research and development activities and raising its profile in Europe. WaferGen is working in partnership with the Integrated Biobank of Luxembourg and maintains offices in the business incubator Luxembourg Technoport. WaferGen is an emerging leader in the development, manufacture, and sale of state-of-the-art systems for genome analysis for the life science and pharmaceutical industries.

Another company that installed its European Headquarter in Luxembourg is Neo Medical Systems. The company collaborates with Luxinnovation and the BioHealth cluster. Founder Francois Scalais submitted a business plan to the 1,2,3,GO programme, which selected the company as a laureate in the 2012 round. With a prototype of a system that provides 3D laparoscopic images in operating rooms, Neo Medical Systems is currently preparing to participate in the Seed4Start initiative to bring in additional financing. Scalais explains: “Luxembourg is great for us.”

 Austria: Connecting East And West

The total revenue in biotech in Austria accounts for approximately 3 billion Euros. The vast majority is generated by only 36 large companies like Boehringer Ingelheim, Sandoz or Sanochemia that have 5,800 employees. In 2010, the research strength of these companies was as high as 107 percent. Innovation hubs are in Tirol, Upper Austria and Styria. The most important innovation hub for biotech, however, is Austria’s capital region, Vienna. Every second biotech company in Austria is based in Vienna.

The cluster LISAvienna connects more than 400 companies, 99 of which are core biotech companies, and 22 research facilities. 9,000 life scientists work in Vienna.

Austria is known for its research funding. In 2011, Austria raised the research rate/premium from eight to 10 percent for expenses in research and development. Companies that invest in innovation get the premium in cash.

“Two national funding agencies, AWS and FFG, fund pre-seed formations of companies with 200,000 Euros”, says Susanne Locker. She is a project manager in the LISAvienna cluster management. “AWS and FFG fund young high-tech-start-ups with one million Euro seed-financing.” The research funding company FFG supports innovative projects financially.

One central funding initiative is the Competence Center for Excellent Technologies (COMET). It aims to strengthen cooperation between industry and academia. During its run duration from 2006 to 2019, 1.5 billion Euros will be invested in industry-oriented research; a great part of this will go to life sciences.

One of Austria’s focus areas is cancer research. The competence center Oncotyrol in Innsbruck has a research volume of 37.5 million Euros until 2015. In 2012, the EU-project OPTATO was started to develop new strategies against an incurable bone marrow tumor. It has a research volume of four million Euros.

Also, the institute of molecular pathology (IMP) that is based at the Campus Vienna Biocenter, enjoys an excellent reputation. More than 200 researchers from all over the world work here. Boehringer Ingelheim invests more than 160 million Euros per year for cancer research in Vienna.

Among the most important research facilities next to IMP and Oncotyrol are the Austrian Institute of Technology (AIT), the Institute of Science and Technology Austria (IST Austria), the Austrian Center for Industrial Biotechnology (acib) and the Research Center Pharmaceutical Engineering (RCPE) in Graz.

The RCPE was founded in 2008 in the context of the funding program COMET. RCPE’s CEO Johannes Khinast says: “With our special research focus, corporations like Pfizer, GlaxoSmithKline, Roche, Novartis, sanofi-aventis, Bayer, AstraZeneca, Abbott or Merck like to partner with us. We work together with 10 renowned research facilities. There are only two comparable non-university research institutes in the world.”

In 2012, pharma-giant Baxter announced it will build a 30 million Euros production facility in Vienna. The company is planning to launch the operating site at the end of 2014. In 2011, Baxter invested approximately 47 million Euros in production sites in Austria. In 2012, the pharmaceutical corporation invested 100 million Euros. In total, the company employs 4,100 people in Austria. Baxter employs 900 people in Vienna and Orth in the field of research and development. Three out of four scientists who work for Baxter around the globe are thus based in Austria. The country is Baxter’s largest site in the world.

In 2012, Austria’s investment agency ABA was able to attract 201 foreign companies across all sectors to start their business or relocate to Austria. They invested 282.4 million Euros. 2,385 new jobs were created, which is an increase of 31 percent, compared to 2011.

One of 11 life science companies that invested in Austria in 2012 is biolitec AG. The German company develops medical laser systems and fiber optics. Biolitec CEO Dr. Wolfgang Neuberger says: “The infrastructure, funding options and flexible group taxation were crucial for our decision to relocate our headquarters to Vienna.”

Texas Biotech Out Of The Labs, Into The Market

In the U.S., the race is on to move promising biotech initiatives out of labs and into commercial production.

In the Lone Star State, a University of Texas spinoff company has pulled in $2 million to test a new technique for culturing non-embryonic stem cells. According to a regulatory filing, StemBioSys raised at least $2 million of a $3.5 million equity offering. CEO Dr. Steven Davis told the San Antonio Business Journal late last year (when the company began raising the round) that it would fund research projects to validate the quality of the stem cells generated by the company’s technology.

StemBioSys is developing XC-marrow ECM, a propriety three-dimensional culture for growing mesenchymal stem cells from bone marrow, adipose tissue and umbilical cord blood. These immature cells have multiple potential uses in research and therapeutics because they can self-renew and mature into a variety of cell types. Stem cell therapies are being studied as a repair mechanism for tissues all over the body, from the heart to the brain to the knees.

The company says its three-dimensional extracellular matrix can grow cells quicker than conventional media while retaining stem cell properties and may help overcome key obstacles in creating stem cell therapies. The technology was developed by Dr. Xiao-Dong Chen, an associate professor of medicine at the University of Texas Health Science Center and the company’s chief scientific officer, and licensed from UT.

Although it’s only available for research purposes now, this kind of technology could have therapeutic applications down the line. “If this research transfers successfully to clinical application in humans, we could establish personal stem cell banks,” Chen said. “We would collect a small number of older stem cells from patients, put those into our young microenvironment to rescue them–increasing their number and quality–then deliver them back into the patient.”

The company has struck a deal with GenCure, an affiliate of the nonprofit South Texas Blood & Tissue Center, to receive mononuclear cells from clinical grade umbilical-cord blood that it uses for R&D purposes. It was founded in 2010 in San Antonio, Texas and has received previous funding from the Texas Technology Development Center’s McDermott Pre-Seed Fund.

Currently, there are more than 160 Austin-area companies with over 8,200 employees operating in the areas of Biotech, Diagnostics, Medical Device, CRO/IRB, Pharma, Biosecurity and Agribio, among others. Texas is one of the leading biotech states in the country, with 3,400 companies and an estimated economic impact of $75 billion.

As relatively young industries in Austin, life science and biotechnology companies enjoy unique successes, with strong growth projected in the areas of biologics/biotech and medical device/diagnostics. Here’s a breakdown of the leading sectors:

• Medical device/diagnostics (40 percent)
• Biologics/biotech (20 percent)
• Contract Research Organizations (20 percent)
• Pharmaceuticals (10 percent)
• Other (11 percent)

Molecular Biotech Center Opens In Salt Lake City

The University of Utah has developed a well-deserved reputation for its research and business innovation, a reputation now enhanced by a new high-tech facility that could promises a financial return as well.

Leaders from the Utah Science Technology and Research Initiative in 2012 dedicated the James L. Sorenson Molecular Biotechnology Building—a $130-million, 208,000-square-foot research facility where scientists, physicians and engineers will collaborate to create new advances in the biotech field.

“The technology that is developed here is going to be a multidisciplinary …cross-pollination of ideas,” said Dinesh Patel, chairman of the USTAR Governing Authority, as reported by KSL.com. Located midway between the engineering and medical areas of campus, the new research building will facilitate increased interaction among faculty and student researchers,

Up to three additional buildings are planned to expand the university’s biotech center.

Financial support for the facility came from $100 million in state bonding and the balance from private donations, including $15 million from the Sorenson Legacy Foundation and $1.25 million from Micron Technology. Construction of the project began in April 2009 and was completed in December 2011. Tenants started moving in last month.

According to the KSL.com report, researchers at the new facility will have the ability to perform “dry” nano (fabrication) for silicon chips, etc., as well as “wet” nano—for use in biomedical devices. The facility also boasts precision equipment, including a $3 million confocal microscope for florescent imaging of cellular processes. Nanofabrication is the design and manufacture of devices with dimensions measured in nanometers. One nanometer is a millionth of a millimeter—less than the diameter of a human hair. The process is of interest to computer engineers because it could open the door to super-high-density microprocessors and memory chips that could one day store a data bit in a single atom.

Since its inception in 2007, USTAR has helped produce more than 300 invention disclosures and patent filings, along with 44 start-up companies or industry partnerships, according to a program statement.

USTAR collaborates with the University of Utah and Utah State University to create world-class research teams in strategic innovation development areas. Highly regarded faculty members, supported by teams of top researchers, lead the teams.

The infrastructure and multidisciplinary nature of the new Sorenson Molecular Biotechnology Building and at the related facility at Utah State University will likely help draw bigger research grants to Utah.

“To successfully win big federal and industry grants takes more complex, collaborative teams of researchers,” Patel told KSL.com. “The physical and intellectual infrastructure this building represents has already helped the U. of U. win a $20 million advanced materials grant.”

The new facility houses the Brain Institute, Nano Institute of Utah and Department of Bioengineering, according to USTAR spokesman Michael O’Malley.

Thus far, the USTAR program has recruited 32 principle researchers to Utah from such prestigious institutions as Harvard, MIT and UCLA. As of Dec. 2011, the researchers have generated nearly $80 million in grants since 2007, with more than $81 million in research proposals pending.

NBAF Bio-Defense Lab Moves Forward In Manhattan, KS

In Kansas, state leaders are celebrating recent progress in the region’s largest biotech project: the National Bio- and Agro-Defense Facility (NBAF), in Manhattan, KS.

The federal Department of Homeland Security signed a formal land transfer agreement with the state to move ahead with NBAF.

“While there is much more work to be done, signing of the land transfer agreement is a good step forward in securing the future health, wealth and security of our nation,” Gov. Sam Brownback said in a news release. “It demonstrates DHS’ continued commitment to completing the NBAF in Manhattan. Kansas stands ready to partner with DHS to move this important national security priority forward.”

Rendering of the National Bio- and Agro- Defense Facility in Kansas

DHS will acquire about 46 acres of land near the north end of Kansas State University for the lab. The transfer clears the way for construction to begin, and a groundbreaking later this year.

NBAF scientists will research animal and human diseases and develop cures and vaccines to counter them. According to the news release, DHS already has invested more than $125 million in the lab, which is expected to cost $650 million. The state has committed $105 million dollars of matching funds for the facility and $35 million dollars of research funding. The project is expected to have a $3.5 billion economic boon to the state in its first 20 years, including 757 construction jobs and 326 permanent positions.

NBAF researchers would study animal-related diseases—including foot-and-mouth disease, classical swine fever, African swine fever, Nipah virus, Japanese Encephalitis, Rift Valley fever and contagious bovine pleuropneuomonia—and develop vaccines and treatments. The facility would be run jointly by Homeland Security and the U.S. Department of Agriculture.

“This was the next step we have all been waiting for and moves us further down the construction timeline,” said U.S. Sen. Pat Roberts. “We will continue to monitor each step in the process to ensure NBAF remains a top national security priority.”

VC Funds Flowing Into Florida Bio Initiatives

The bioscience industry in Florida is on the rise in terms of new companies and venture capital flowing into businesses, according to BioFlorida, an industry trade organization.

Venture funding for the industry in 2012, for example, rose 19 percent over 2011, to $103.5 million, according to a BioFlorida release. That was the best year for venture capital in the industry since 2007. Plus, the amount of deals rose from 15 in 2011 to 19 in 2012.

The amount of biotech start-up companies in the sector is growing, too. BioFlorida reports that tally is up 13.5 percent since the first quarter of 2012.

The statewide data comes from a University of Florida Sid Martin Biotechnology Incubator report. “The new data is evidence of a strong, innovative and sustainable bioscience business climate here in Florida,” says David Day, assistant vice president of the University of Florida Office of Technology Licensing and the Sid Martin Biotechnology Incubator.

“Not only is Florida experiencing growth in the number of biotechnology businesses, we are also seeing a continued increase in venture capital investments—demonstration of investor confidence in our biotechnology start-ups and breakthrough research,” Day added.

Naples-based biotechnology firm Kirax is planning a new high-rise headquarters. “My goal is to continue to expand Kirax in Naples,” said Edmundo Muniz, president and CEO of Kirax, which develops pharmaceuticals, in an interview with the Naples Daily News. “You will see a big tall building in Naples with the word ‘Kirax’ across the top.”

Southwest Florida is playing catch-up with other regions of the state in developing a biotech cluster. Of the 219 biotechnology companies based in Florida, seven of them are located in Southwest Florida, according to Florida BioDatabase. That puts the region sixth out of the state’s eight regions in terms of numbers of biotech companies, tied with Northeast Florida and behind the Panhandle and Central Florida, according to the database.

Florida experienced a biotech boom from 2006 through 2011, with the number of companies growing by 42 percent compared to just 5 percent nationwide, the university’s Florida BioPulse report shows. More than 10 percent of the nation’s biotech companies call Florida home.

The report gives much of the credit to then-Gov. Jeb Bush, who pushed a controversial $310 million incentive package through the state Legislature to lure the Scripps Research Institute to Palm Beach County, which threw in another $187 million for the first phase of construction.

The institute specializes in biomedical research. It opened in 2009. Scripps “opened up the dam” for biotech in Florida, said Patti Breedlove, associate director of UF’s Sid Martin Biotechnology Incubator.

“That was a pivotal moment,” she said. “People stopped laughing about the possibilities of biotech in Florida.”

Getting Southwest Florida a larger share of the biotechnology pie isn’t “on our radar now,” said Michael Wynn, co-chairman of The Partnership for Collier’s Future Economy, an arm of the Greater Naples Chamber of Commerce.

He said he sees a “huge potential” for attracting biotechnology firms when the county is ready to redirect its focus there, citing the region’s quality of life and the plethora of CEOs that live here and whose connections with the biotech world could be tapped.

In Estero, Florida Gulf Coast University’s fledgling biotechnology program has graduated 40 students, and is setting its sights on creating a master’s and doctorate degree program, said Takashi Ueda, an associate professor of biology and the biotechnology program leader. A 241-acre research park, dubbed Innovation Hub, is planned to break ground at FGCU in early 2013 with a focus on renewable energy sources, including biotech.

Roche Breaks Ground On Indy Learning Center

Late last year, Indianapolis Mayor Greg Ballard joined Roche Diagnostics President and CEO Jack Phillips as well as other Roche executives and community leaders to break ground on the company’s new Learning and Development Center. The center is the first element of a $300 million site transformation investment that was announced in June 2012. The city of Indianapolis and the Indiana Economic Development Corporation offered Roche tax abatements, tax credits and training grants.

“Roche has been an important part of our life sciences heritage for nearly 50 years now, and this expansion signals an important commitment to the region,” said Ballard.

“Central Indiana has been our home since 1964 and we are here to stay,” said Jack Phillips, president and CEO of Roche Diagnostics, adding that the company’s history and growth in the region is due in part to the community’s outstanding workforce and partnerships with the state and city that have enhanced job creation.

The capital investments at Roche’s North American headquarters on the northeast side of Indianapolis will support the company’s growing diagnostics and diabetes care businesses.  The new Learning and Development Center will host the training of more than 1,500 customers from across the nation each year.

“As a key piece of our North American Headquarters, the new Learning and Development Center will serve as a hub and gateway for worldwide operations,” said Phillips. “We felt that it was important for the building to reflect our global influence, right here in Indianapolis.”

Mississippi Medical Center Unveils New Research Hub

Construction of a new research building, which will include space for start-up biotechnology companies, is commencing this year at University of Mississippi Medical Center in Fondren. UMC leaders plan to spend $35 million initially on the eight-story shell of the Cancer and Biomedical Science Research Center and plan to finish the ground, first and second-floor interiors of the 220,000 square-foot building. That work should take about 18 months. Contractors would complete additional floors as funds become available. “We have very limited amounts of research space right now,” said Dr. John Hall, UMMC associate vice chancellor for research. “This building will help us recruit scientists, expand our research centers and institutes, and develop the Biotechnology Research Park at UMMC.”

Biotech company incubator space will occupy about 25,000 square feet on one floor. That will mark the first phase of a long-term plan to construct the Mississippi Biotechnology Research Park. The building also will house laboratory animal facilities and UMMC Cancer Institute labs. Hall said administrators will survey space needs of departments and research centers. UMMC leaders put plans on hold last year for a Mississippi Biotechnology Research Park project at the old farmers market when Congress swore off federally targeted funds, known as earmarks. The project already had received nearly $20 million in federal earmarks, and UMMC had taken ownership of the farmer’s market property, located at West Street and Woodrow Wilson Avenue. With little likelihood of further federal support, administrators opted to include biotech incubator space in the Cancer and Biomedical Science Research Center, which allowed use of the $20 million for the on-campus building.

Frederick County, MD: U.S. Biotech Research Hub

Frederick County, Maryland, is the prime location for bioscience companies to establish and continue their dynamic success in a global marketplace. Already home to more than 70 cutting edge bioscience companies, Frederick County has the second largest cluster of bioscience companies in Maryland.

In fact, Maryland is home to the highest concentration of federal biotech research facilities, anchored by the National Institutes of Health (NIH). Taken together, Maryland’s bioscience research complex is conservatively estimated to represent nearly $8 billion in research and development expenditures annually, third in total size only to California and New Jersey. The state also has a leadership position in academic R&D per capita, led by Johns Hopkins University, the top recipient of NIH funding in the U.S.

MedImmune is completing work on its $600-million Frederick Manufacturing Center, which will employ 250; when it ramps up to full production the center is expected to be the largest bulk biotech manufacturing facility in the United States.

Frederick County’s burgeoning biotech cluster continues to expand exponentially. A good example is MedImmune, now part of AstraZeneca, which recently completed its $250-million, 337,000- square-foot Frederick Manufacturing Center, creating 200 new jobs and bringing total employment to 450. The Frederick facility will be one of the biggest bulk biotech manufacturing facilities in the country. The workforce at the $600-million facility is expected to double when the plant ramps up to full production. MedImmune also has expanded its headquarters complex in Gaithersburg, investing $200 million and increasing the lab staff to 600.

Qiagen, a Netherlands-based supplier of sample and assay technologies in the life sciences sector, expanded its North American headquarters and manufacturing center in Germantown. The $2-million, four-phase expansion is adding about 90 new jobs. Qiagen employs more than 3,500 globally, including nearly 700 across its three locations in Maryland at Germantown, Gaithersburg and Frederick.

Lonza Bioscience invested $26 million in an expansion of its cell production and office space in Walkersville, adding 80 employees bringing total employment to 480. Additionally, Life Technologies undertook a $5 million expansion of their life sciences manufacturing distribution center.

Many new and expanding bioscience companies choose Frederick County as their preferred business location for the following reasons:

• Business Friendly Environment
• No business personal property tax
• Competitive tax structure
• Fast Track permitting assistance
• Start-up companies benefit from a high-tech incubator at Frederick Innovative Technology Center

Recent bioscience expansions also include the Fort Detrick National Interagency Biodefense Campus; new laboratories and office for Interagency Biodefense R&D and new facilities at the SAIC-Frederick, Inc./National Cancer Institute.

Maryland Gov. Martin O’Malley is seeking to spur biotech development with his $100-million InvestMaryland program, which would provide tax credits to insurance companies so they could invest in technology companies, including biotech research facilities. The state also is well under way with its Bio 2020 plan to invest at least $1.3 billion in biotech across the decade. The 15-year-old Maryland Venture Fund, which makes direct investments in technology and life sciences early-stage companies, has invested $25 million and returned more than double that investment.

Under the Bio 2020 plan, the Maryland Biotechnology Center was established within the Maryland Department of Business and Economic Development to coordinate a host of state, university and private sector initiatives to support biotechnology innovation and entrepreneurship in Maryland. The Center works closely with university technology transfer offices and commercialization programs such as the Maryland Technology Development Corporation (TEDCO) and the University of Maryland’s Maryland Industrial Partnerships (MIPS) program to foster and fund collaborative initiatives between bioscience enterprises, universities, and federal labs. In certain qualifying cases, the Center can supplement funding of industry-university and industry-federal labs research partnerships.

The Center has created a BioEntreprenuer Resources Program which assists entrepreneurs in leveraging available public and private capital. The Center also works closely with the University of Maryland School of Law’s Intellectual Property Legal Resource Center (MIPLRC). The MIPLRC provides free legal services on the subjects of business and intellectual property to start-up bioscience enterprises.

Higher-Ed Partnering For Progress In Minnesota

A biotechnology partnership has been initiated between Minneapolis Community and Technical College (MCTC) and the University of Minnesota. In addition to the transferability of the Biotechnology program in its entirety, the partnership ensures graduates of MCTC’s Biotechnology program with grade point averages of 3.5 or higher will be enrolled at the College of Biological Sciences at the University of Minnesota, one of the University’s most prestigious schools.

“Minnesota has earned its place in the medical device industry by nurturing scientists,” said LifeScience Alley President and CEO Dale Wahlstrom. “This partnership moves students between two strong academic programs to graduate studies or careers in Minnesota’s famed bioscience sector.”

The first cohort within the new biotechnology partnership includes seven MCTC students. MCTC’s Biotechnology faculty leader Rekha Ganaganur noted all seven of the students have undergraduate research or internship experiences and some have obtained jobs in the bioscience industry. She applauded the vision of Robert Elde, the dean of the University of Minnesota’s College of Biological Sciences. “Dean Elde knows Minnesotans want colleges to collaborate to enhance the biotechnology workforce of the future.” Ganaganur is grateful for the LifeScience Alley membership for serving on the MCTC advisory group which made the partnership possible.

Elde and Ganaganur pledged their programs to support students who start their academic careers at community colleges. MCTC program participants can consider themselves University students as they grow their academic careers. “The partnership is a positive example of a collaborative effort that will help ensure a pathway for students to the top scientific careers in our state,” said MCTC President Phil Davis. “I am extremely impressed with the caliber of students enrolled in our programs, and MCTC welcomes this as a way to encourage academic success.”

New Jersey New Incentives For On-The-Job Training

NJ Gov. Chris Christie Administration recently announced that financial hiring incentives are now available to employers through the state Department of Labor and Workforce Development (LWD) if they hire and train former pharmaceutical industry employees. Employers willing to hire displaced pharmaceutical workers may reduce the cost to train new employees under this new on-the-job training program, which will reimburse each employer up to 50 to 90 percent of a new hire’s salary for up to six months and a maximum of $14,000.

“As a former business owner, I fully understand the expense associated with training new employees.  This is an opportunity for employers to bring on new staff and offset their training costs. This program benefits employers and employees and will help stimulate job growth here in New Jersey,” said Dept. of LWD Commissioner Harold J. Wirths.

New Jersey employers from all industries are eligible to participate in this program, which is commonly known as an On-the-Job-Training program, as long as the prospective new hires are among the former pharmaceutical industry workers covered under a National Emergency Grant first issued to the LWD by the U.S. Department of Labor in 2010.

The program is managed in collaboration with the state’s Life Sciences Talent Network at BioNJ. It is designed to help workers who were displaced from the pharmaceutical industry due to the economic downturn by providing job training and assistance in finding new employment. New Jersey applied for the grant to keep the state’s pharmaceutical talent in the state and maintain New Jersey’s economic competitiveness. The workers covered under the grant include those who were displaced from approved locations of Bristol-Myers Squibb, Hoffman-La Roche, Johnson & Johnson, Merck & Co., and Pfizer companies.

Under the new On-the-Job Training component, employers will not incur any fees and LWD or the Life Sciences Talent Network staff will pre-screen applicants for eligibility or will assist in qualifying candidates prior to the actual hire. New Jersey also is paving the way for increased cooperation between the state’s bio-pharma industry and academia.

Lt. Governor Kim Guadagno recently announced the formation of a new Council on Innovation to advise the NJ Partnership for Action on how industry and academia can better work together to improve New Jersey’s economy and attract more federal funding. Creation of the Council is among 15 recommendations in a report released by New Jersey Policy Research Organization (NJPRO) and Innovation NJ. In addition, Lt. Governor Guadagno announced Secretary of Higher Education Rochelle Hendricks as the newest member of the NJ Partnership for Action. The report recommends policy changes that would create an “innovation ecosystem,” making it easier for industry and academia to collaborate on new ideas and inventions.

Other recommendations include cutting red tape by creating standard agreements governing intellectual property rights and collaboration between entities. Identifying areas of expertise within New Jersey’s colleges and universities that can form the basis for Centers of Excellence. Designation of a single center of excellence for a topic would provide guidance to interested parties searching for a research partner; having a chief administrator at each college and university who will serve as a one-stop shop coordinator for businesses to connect with university information and resources.

Secretary Hendricks emphasized the importance of aligning businesses and academic institutions to grow New Jersey’s economy, attract more federal funds and bring innovative products and ideas to market.

“We need to be efficient and effective to win the competition to market commercial ideas and products,” she said. “Many of our academic institutions are already doing ground-breaking research. With improved collaboration among state agencies, colleges and businesses, that research can be directly connected with the economy, helping our institutions continue to compete on a national and global scale.”

Kentucky Spreads Seed Capital To Bio Start-Ups

Kentucky is offering a host of programs geared to jumpstart biotech start-ups. Commonwealth Seed Capital, LLC (CSC) is an independent fund that makes debt or equity investments in early-stage Kentucky business entities to facilitate the commercialization of innovative ideas and technologies. Investments are typically made in these specified innovation areas: health and human development; information technology and communications; bioscience; environmental and energy technologies; and materials science and advanced manufacturing.  CSC invests in companies that have a significant Kentucky presence, the prospect for substantial growth and the potential to generate an appropriate rate of return.

The Kentucky Cabinet for Economic Development also offers a matching funds program to facilitate biotech start-ups. The Cabinet will match, on a competitive basis, Phase 1 and Phase 2 federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) awards received by Kentucky high-tech small businesses and those willing to become Kentucky-based businesses.

This includes matching Phase 1 federal awards up to $150,000 to support the exploration of the technical merit or feasibility of an idea or technology. The program also provides up to $500,000 of federal Phase 2 awards, which support full-scale research and development.

The post COVER STORY: Global Biotech Report appeared first on Business Facilities.